{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import snorkel\n",
    "from snorkel.labeling import labeling_function\n",
    "from snorkel.labeling import LabelingFunction\n",
    "from snorkel.labeling import PandasLFApplier\n",
    "from snorkel.labeling import LFAnalysis\n",
    "from snorkel.labeling.model import MajorityLabelVoter\n",
    "import json\n",
    "import pandas as pd\n",
    "import label_improve"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The autoreload extension is already loaded. To reload it, use:\n",
      "  %reload_ext autoreload\n"
     ]
    }
   ],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2\n",
    "import label_improve as li"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Loading the data \n",
    "dataset_name = \"chemprot\"\n",
    "\n",
    "idx_to_label = json.load(open(f\"../weak_datasets/{dataset_name}/label.json\"))\n",
    "label_to_idx = {l:i for i,l in idx_to_label.items()}\n",
    "valid_df = li.chemprot_to_df(json.load(open(f\"../weak_datasets/{dataset_name}/valid.json\", \"r\")))\n",
    "train_df = li.chemprot_to_df(json.load(open(f\"../weak_datasets/{dataset_name}/train.json\", \"r\")))\n",
    "test_df = li.chemprot_to_df(json.load(open(f\"../weak_datasets/{dataset_name}/test.json\", \"r\")))\n",
    "\n",
    "# Sample a dev set to help seed ideas for LFs\n",
    "dev_df = train_df.sample(250, random_state=123)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "# chemprot functions:\n",
    "\n",
    "ABSTAIN = -1\n",
    "### Keyword based labeling functions ###\n",
    "\n",
    "## Part of\n",
    "#0\n",
    "@labeling_function()\n",
    "def lf_amino_acid(x):\n",
    "    return 0 if 'amino acid' in x.sentence.lower() else ABSTAIN\n",
    "#1\n",
    "@labeling_function()\n",
    "def lf_replace(x):\n",
    "    return 0 if 'replace' in x.sentence.lower() else ABSTAIN\n",
    "#2\n",
    "@labeling_function()\n",
    "def lf_mutant(x):\n",
    "    return 0 if 'mutant' in x.sentence.lower() or 'mutat' in x.sentence.lower() else ABSTAIN\n",
    "#3\n",
    "## Regulator\n",
    "@labeling_function()\n",
    "def lf_bind(x):\n",
    "    return 1 if 'bind' in x.sentence.lower() else ABSTAIN\n",
    "#4\n",
    "@labeling_function()\n",
    "def lf_interact(x):\n",
    "    return 1 if 'interact' in x.sentence.lower() else ABSTAIN\n",
    "#5\n",
    "@labeling_function()\n",
    "def lf_affinity(x):\n",
    "    return 1 if 'affinit' in x.sentence.lower() else ABSTAIN\n",
    "#6\n",
    "## Upregulator\n",
    "# Activator\n",
    "@labeling_function()\n",
    "def lf_activate(x):\n",
    "    return 2 if 'activat' in x.sentence.lower() else ABSTAIN\n",
    "#7\n",
    "@labeling_function()\n",
    "def lf_increase(x):\n",
    "    return 2 if 'increas' in x.sentence.lower() else ABSTAIN\n",
    "#8 \n",
    "@labeling_function()\n",
    "def lf_induce(x):\n",
    "    return 2 if 'induc' in x.sentence.lower() else ABSTAIN\n",
    "#9\n",
    "@labeling_function()\n",
    "def lf_stimulate(x):\n",
    "    return 2 if 'stimulat' in x.sentence.lower() else ABSTAIN\n",
    "#10\n",
    "@labeling_function()\n",
    "def lf_upregulate(x):\n",
    "    return 2 if 'upregulat' in x.sentence.lower() else ABSTAIN\n",
    "#11\n",
    "## Downregulator\n",
    "@labeling_function()\n",
    "def lf_downregulate(x):\n",
    "    return 3 if 'downregulat' in x.sentence.lower() or 'down-regulat' in x.sentence.lower() else ABSTAIN\n",
    "#12\n",
    "@labeling_function()\n",
    "def lf_reduce(x):\n",
    "    return 3 if 'reduc' in x.sentence.lower() else ABSTAIN\n",
    "#13\n",
    "@labeling_function()\n",
    "def lf_inhibit(x):\n",
    "    return 3 if 'inhibit' in x.sentence.lower() else ABSTAIN\n",
    "#14\n",
    "@labeling_function()\n",
    "def lf_decrease(x):\n",
    "    return 3 if 'decreas' in x.sentence.lower() else ABSTAIN\n",
    "#15\n",
    "## Agonist\n",
    "@labeling_function()\n",
    "def lf_agonist(x):\n",
    "    return 4 if ' agoni' in x.sentence.lower() or \"\\tagoni\" in x.sentence.lower() else ABSTAIN\n",
    "\n",
    "#16\n",
    "## Antagonist\n",
    "@labeling_function()\n",
    "def lf_antagonist(x):\n",
    "    return 5 if 'antagon' in x.sentence.lower() else ABSTAIN\n",
    "\n",
    "#17\n",
    "## Modulator\n",
    "# TODO: Delete this LF, or change this to modulator ??\n",
    "@labeling_function()\n",
    "def lf_modulate(x):\n",
    "    return 6 if 'modulat' in x.sentence.lower() else ABSTAIN\n",
    "\n",
    "#18\n",
    "@labeling_function()\n",
    "def lf_allosteric(x):\n",
    "    return 6 if 'allosteric' in x.sentence.lower() else ABSTAIN\n",
    "#19\n",
    "## Cofactor\n",
    "@labeling_function()\n",
    "def lf_cofactor(x):\n",
    "    return 7 if 'cofactor' in x.sentence.lower() else ABSTAIN\n",
    "#20\n",
    "## Substrate/Product\n",
    "@labeling_function()\n",
    "def lf_substrate(x):\n",
    "    return 8 if 'substrate' in x.sentence.lower() else ABSTAIN\n",
    "#21\n",
    "@labeling_function()\n",
    "def lf_transport(x):\n",
    "    return 8 if 'transport' in x.sentence.lower() else ABSTAIN\n",
    "#22\n",
    "@labeling_function()\n",
    "def lf_catalyze(x):\n",
    "    return 8 if 'catalyz' in x.sentence.lower() or 'catalys' in x.sentence.lower() else ABSTAIN\n",
    "#23\n",
    "@labeling_function()\n",
    "def lf_product(x):\n",
    "    return 8 if \"produc\" in x.sentence.lower() else ABSTAIN\n",
    "#24\n",
    "@labeling_function()\n",
    "def lf_convert(x):\n",
    "    return 8 if \"conver\" in x.sentence.lower() else ABSTAIN\n",
    "#25\n",
    "## NOT\n",
    "@labeling_function()\n",
    "def lf_not(x):\n",
    "    return 9 if 'not' in x.sentence.lower() else ABSTAIN\n",
    "\n",
    "# 26 \n",
    "@labeling_function()\n",
    "def lf_combined_modulator(x):\n",
    "    sentence_lower = x.text.lower()\n",
    "\n",
    "    # Specific Modulation Terms\n",
    "    specific_terms = ['allosteric modulator', 'positive modulator', 'negative modulator', 'non-competitive modulator', 'positive allosteric modulator']\n",
    "    if any(term in sentence_lower for term in specific_terms):\n",
    "        return 6\n",
    "\n",
    "    # Entity-Proximity Modulation\n",
    "    modulating_terms = ['modulat', 'allosteric', 'potentiate', 'regulate']\n",
    "    for term in modulating_terms:\n",
    "        if term in sentence_lower:\n",
    "            term_index = sentence_lower.index(term)\n",
    "            if abs(term_index - x.entity1_index) < 20 or abs(term_index - x.entity2_index) < 20:\n",
    "                return 6\n",
    "\n",
    "    # Combined Entity and Action Modulation\n",
    "    if x.entity1 in sentence_lower and x.entity2 in sentence_lower:\n",
    "        entity1_index = sentence_lower.index(x.entity1.lower())\n",
    "        entity2_index = sentence_lower.index(x.entity2.lower())\n",
    "        between_entities = sentence_lower[min(entity1_index, entity2_index):max(entity1_index, entity2_index)]\n",
    "        if 'modulate' in between_entities or 'regulate' in between_entities:\n",
    "            return 6\n",
    "\n",
    "    # Positive and Modulator Proximity\n",
    "    if 'positive' in sentence_lower and 'modulator' in sentence_lower:\n",
    "        pos_indices = [i for i, word in enumerate(sentence_lower.split()) if word == 'positive']\n",
    "        mod_indices = [i for i, word in enumerate(sentence_lower.split()) if 'modulator' in word]\n",
    "        min_distance = min(abs(p - m) for p in pos_indices for m in mod_indices)\n",
    "        if min_distance <= 3:\n",
    "            return 6\n",
    "\n",
    "    return ABSTAIN\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>labels</th>\n",
       "      <th>entity1</th>\n",
       "      <th>entity2</th>\n",
       "      <th>span1</th>\n",
       "      <th>span2</th>\n",
       "      <th>weak_labels</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>10305</th>\n",
       "      <td>Selective inhibition of PDE5 is a rational therapeutic approach in ED, as proved by the clinical success of sildenafil.</td>\n",
       "      <td>3</td>\n",
       "      <td>PDE5</td>\n",
       "      <td>sildenafil</td>\n",
       "      <td>[24, 28]</td>\n",
       "      <td>[108, 118]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8422</th>\n",
       "      <td>Furthermore, knockdown of OPN enhanced cell death caused by other drugs, including paclitaxel, doxorubicin, actinomycin-D, and rapamycin, which are also P-gp substrates.</td>\n",
       "      <td>8</td>\n",
       "      <td>P-gp</td>\n",
       "      <td>paclitaxel</td>\n",
       "      <td>[153, 157]</td>\n",
       "      <td>[83, 93]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8486</th>\n",
       "      <td>Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFα levels) was seen in LPS-stimulated human PBMCs, except with JWH-210 and JWH-122 which caused a decrease of TNFα and IL-12/23p40.</td>\n",
       "      <td>3</td>\n",
       "      <td>IL-12</td>\n",
       "      <td>JWH-210</td>\n",
       "      <td>[203, 208]</td>\n",
       "      <td>[147, 154]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6254</th>\n",
       "      <td>Among neuroleptics, the four most potent compounds at the human serotonin transporter were triflupromazine, fluperlapine, chlorpromazine, and ziprasidone (K(D) 24-39 nM); and at the norepinephrine transporter, chlorpromazine, zotepine, chlorprothixene, and promazine (K(D) 19-25 nM).</td>\n",
       "      <td>1</td>\n",
       "      <td>norepinephrine transporter</td>\n",
       "      <td>chlorpromazine</td>\n",
       "      <td>[182, 208]</td>\n",
       "      <td>[210, 224]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1801</th>\n",
       "      <td>Epidermal growth factor receptor inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux).</td>\n",
       "      <td>3</td>\n",
       "      <td>Epidermal growth factor receptor</td>\n",
       "      <td>Tarceva</td>\n",
       "      <td>[0, 32]</td>\n",
       "      <td>[144, 151]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>The high-affinity binding of L-noradrenaline to phenylalanine hydroxylase, as studied by equilibrium microdialysis (anaerobically) and ultrafiltration (aerobically), shows positive cooperativity (h = 1.9); at pH 7.2 and 20 degrees C the rat enzyme binds about 0.5 mol L-noradrenaline/mol subunit with a half-maximal binding (S50) at 0.25 microM L-noradrenaline.</td>\n",
       "      <td>1</td>\n",
       "      <td>phenylalanine hydroxylase</td>\n",
       "      <td>L-noradrenaline</td>\n",
       "      <td>[48, 73]</td>\n",
       "      <td>[268, 283]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5981</th>\n",
       "      <td>Tyrosinase catalyzes an unusual oxidative decarboxylation of 3,4-dihydroxymandelate.</td>\n",
       "      <td>8</td>\n",
       "      <td>Tyrosinase</td>\n",
       "      <td>3,4-dihydroxymandelate</td>\n",
       "      <td>[0, 10]</td>\n",
       "      <td>[61, 83]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6865</th>\n",
       "      <td>Jo2-induced activation of caspase-3 or -9 in liver tissues was inhibited by minocycline pretreatment, and yet the direct addition of minocycline to liver extracts from Jo2-challenged mice failed to block caspase activation in vitro.</td>\n",
       "      <td>9</td>\n",
       "      <td>caspase</td>\n",
       "      <td>minocycline</td>\n",
       "      <td>[204, 211]</td>\n",
       "      <td>[133, 144]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, 2, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9540</th>\n",
       "      <td>Lintitript markedly increased postprandial plasma CCK release (P&lt;0.001) while distinctly reducing postprandial PP levels (P&lt;0.01) as compared to placebo.</td>\n",
       "      <td>2</td>\n",
       "      <td>CCK</td>\n",
       "      <td>Lintitript</td>\n",
       "      <td>[50, 53]</td>\n",
       "      <td>[0, 10]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13166</th>\n",
       "      <td>Progestin induction of the cyclin D1 gene, which lacks a progesterone response element, was dependent on PR activation of the Src/MAPK pathway, whereas induction of the Sgk (serum and glucocorticoid regulated kinase) gene that contains a functional progesterone response element was unaffected by mutations that interfere with PR activation of Src.</td>\n",
       "      <td>1</td>\n",
       "      <td>Sgk</td>\n",
       "      <td>Progestin</td>\n",
       "      <td>[169, 172]</td>\n",
       "      <td>[0, 9]</td>\n",
       "      <td>[-1, -1, 0, -1, -1, -1, 2, -1, 2, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15588</th>\n",
       "      <td>Exploring the effect of N-substitution in nor-lobelane on the interaction with VMAT2: discovery of a potential clinical candidate for treatment of methamphetamine abuse.</td>\n",
       "      <td>1</td>\n",
       "      <td>VMAT2</td>\n",
       "      <td>N</td>\n",
       "      <td>[79, 84]</td>\n",
       "      <td>[24, 25]</td>\n",
       "      <td>[-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013</th>\n",
       "      <td>Pranlukast-induced inhibition of IL-5 mRNA expression was noted in various cells, irrespective of their CysLTR1 mRNA expression status.</td>\n",
       "      <td>3</td>\n",
       "      <td>IL-5</td>\n",
       "      <td>Pranlukast</td>\n",
       "      <td>[33, 37]</td>\n",
       "      <td>[0, 10]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 9]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4064</th>\n",
       "      <td>Among the isolated compounds, trans-dihydromorin (8), oxyresveratrol (9), and steppogenin (12) were found to exhibit significant tyrosinase inhibition activities.</td>\n",
       "      <td>3</td>\n",
       "      <td>tyrosinase</td>\n",
       "      <td>trans-dihydromorin</td>\n",
       "      <td>[129, 139]</td>\n",
       "      <td>[30, 48]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2878</th>\n",
       "      <td>Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.</td>\n",
       "      <td>3</td>\n",
       "      <td>dipeptidyl peptidase-4</td>\n",
       "      <td>sitagliptin</td>\n",
       "      <td>[27, 49]</td>\n",
       "      <td>[61, 72]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11828</th>\n",
       "      <td>To explore the molecular basis for CPT hypersensitivity in Top2β-deficient cells, we found that upon CPT exposure, the RNA polymerase II large subunit (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2β-deficient cells.</td>\n",
       "      <td>3</td>\n",
       "      <td>RNA polymerase II large subunit</td>\n",
       "      <td>CPT</td>\n",
       "      <td>[119, 150]</td>\n",
       "      <td>[101, 104]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14046</th>\n",
       "      <td>Aspirin and metformin (an activator of AMPK) increased inhibition of mTOR and Akt, as well as autophagy in CRC cells.</td>\n",
       "      <td>2</td>\n",
       "      <td>AMPK</td>\n",
       "      <td>metformin</td>\n",
       "      <td>[39, 43]</td>\n",
       "      <td>[12, 21]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, 2, 2, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10088</th>\n",
       "      <td>A series of studies is reviewed that assesses the relationship between cytokines released at the site of tissue injury and NSAID analgesia, and the in vivo selectivity of a selective cyclooxygenase (COX)-2 inhibitor (celecoxib) in comparison to a dual COX-1/COX-2 inhibitor (ketorolac).</td>\n",
       "      <td>3</td>\n",
       "      <td>COX-2</td>\n",
       "      <td>ketorolac</td>\n",
       "      <td>[258, 263]</td>\n",
       "      <td>[275, 284]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14461</th>\n",
       "      <td>Loss of agonist binding was observed on intact human embryonic kidney 293 cells expressing the W203A receptor, conditions where high GTP levels are present; however, high affinity binding [(3)H]PGE(2) was observed in broken cell preparations washed free of GTP.</td>\n",
       "      <td>1</td>\n",
       "      <td>W203A</td>\n",
       "      <td>[(3)H]PGE(2)</td>\n",
       "      <td>[95, 100]</td>\n",
       "      <td>[188, 200]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 4, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5908</th>\n",
       "      <td>Absorbable drugs (fibric acids, nicotinic acid, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or low-density lipoproteins (LDL) by a variety of mechanisms.</td>\n",
       "      <td>3</td>\n",
       "      <td>VLDL</td>\n",
       "      <td>probucol</td>\n",
       "      <td>[133, 137]</td>\n",
       "      <td>[48, 56]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1499</th>\n",
       "      <td>Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.</td>\n",
       "      <td>3</td>\n",
       "      <td>Bad</td>\n",
       "      <td>Sulindac sulfide</td>\n",
       "      <td>[116, 119]</td>\n",
       "      <td>[0, 16]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4491</th>\n",
       "      <td>The hemoglobin A1c (HbA1c) of all patients improved significantly from 8.1±1.2% to 7.6±1.1% after 12 weeks of add-on therapy with sitagliptin (p&lt;0.01), and the insulin dosage was reduced from 27.3±15.8 U/day to 24.5±16.5 U/day (p&lt;0.001).</td>\n",
       "      <td>2</td>\n",
       "      <td>HbA1c</td>\n",
       "      <td>sitagliptin</td>\n",
       "      <td>[20, 25]</td>\n",
       "      <td>[130, 141]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9342</th>\n",
       "      <td>The relative potency of compounds in displacing [3H]-kainate binding to EAA3a receptor was: domoate &gt; kainate &gt; L-glutamate = quisqualate &gt; 6,7-dinitroquinoxaline-2,3-dione (DNQX) = CNQX &gt; AMPA &gt; dihydrokainate &gt; NMDA.</td>\n",
       "      <td>1</td>\n",
       "      <td>EAA3a</td>\n",
       "      <td>AMPA</td>\n",
       "      <td>[72, 77]</td>\n",
       "      <td>[189, 193]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13752</th>\n",
       "      <td>The L-type calcium channel (LTCC) isoforms Ca(v)1.2 and Ca(v)1.3 display similar 1,4-dihydropyridine (DHP) binding properties and are both expressed in mammalian brain.</td>\n",
       "      <td>1</td>\n",
       "      <td>L-type calcium channel</td>\n",
       "      <td>1,4-dihydropyridine</td>\n",
       "      <td>[4, 26]</td>\n",
       "      <td>[81, 100]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6466</th>\n",
       "      <td>Pemetrexed disodium (Alimta, LY231514) is a novel, multitargeted antifolate that inhibits thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyl transferase.</td>\n",
       "      <td>3</td>\n",
       "      <td>glycinamide ribonucleotide formyl transferase</td>\n",
       "      <td>LY231514</td>\n",
       "      <td>[141, 186]</td>\n",
       "      <td>[29, 37]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2721</th>\n",
       "      <td>Cisapride was found to bind the human ether-a-go-go-related gene (HERG) potassium channel, which provides a plausible mechanism for QTc interval prolongation/arrhythmia.</td>\n",
       "      <td>1</td>\n",
       "      <td>human ether-a-go-go-related gene (HERG) potassium channel</td>\n",
       "      <td>Cisapride</td>\n",
       "      <td>[32, 89]</td>\n",
       "      <td>[0, 9]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12577</th>\n",
       "      <td>This cDNA clone, designated EAA3a, shares a 90% nucleotide identity with the previously reported rat GluR5-2b cDNA splice variant and differed from human GluR5-1d in the amino and carboxy terminal regions.</td>\n",
       "      <td>0</td>\n",
       "      <td>human GluR5-1d</td>\n",
       "      <td>amino</td>\n",
       "      <td>[148, 162]</td>\n",
       "      <td>[170, 175]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4294</th>\n",
       "      <td>Uptake of the radiolabeled model substrates estradiol 17β-glucuronide, estrone 3-sulfate, and dehydroepiandrosterone sulfate (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either OATP1B1 or OATP1B3.</td>\n",
       "      <td>8</td>\n",
       "      <td>OATP1B1</td>\n",
       "      <td>dehydroepiandrosterone sulfate</td>\n",
       "      <td>[258, 265]</td>\n",
       "      <td>[94, 124]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1604</th>\n",
       "      <td>5-(N,N-dimethyl)-amiloride (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.</td>\n",
       "      <td>3</td>\n",
       "      <td>NHE2</td>\n",
       "      <td>5-(N,N-dimethyl)-amiloride</td>\n",
       "      <td>[113, 117]</td>\n",
       "      <td>[0, 26]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 9]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11794</th>\n",
       "      <td>Fisetin treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and IL-1β (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.</td>\n",
       "      <td>3</td>\n",
       "      <td>glycosylated hemoglobin</td>\n",
       "      <td>Fisetin</td>\n",
       "      <td>[79, 102]</td>\n",
       "      <td>[0, 7]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3035</th>\n",
       "      <td>PGE(2) is synthesized from arachidonic acid by cyclooxygenases (COX) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).</td>\n",
       "      <td>1</td>\n",
       "      <td>prostanoid receptors EP(1)</td>\n",
       "      <td>PGE(2)</td>\n",
       "      <td>[171, 197]</td>\n",
       "      <td>[0, 6]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                            text  \\\n",
       "10305                                                                                                                                                                                                                                                    Selective inhibition of PDE5 is a rational therapeutic approach in ED, as proved by the clinical success of sildenafil.   \n",
       "8422                                                                                                                                                                                                   Furthermore, knockdown of OPN enhanced cell death caused by other drugs, including paclitaxel, doxorubicin, actinomycin-D, and rapamycin, which are also P-gp substrates.   \n",
       "8486                                                                                                                                                     Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFα levels) was seen in LPS-stimulated human PBMCs, except with JWH-210 and JWH-122 which caused a decrease of TNFα and IL-12/23p40.   \n",
       "6254                                                                                 Among neuroleptics, the four most potent compounds at the human serotonin transporter were triflupromazine, fluperlapine, chlorpromazine, and ziprasidone (K(D) 24-39 nM); and at the norepinephrine transporter, chlorpromazine, zotepine, chlorprothixene, and promazine (K(D) 19-25 nM).   \n",
       "1801                                                                                                                                   Epidermal growth factor receptor inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux).   \n",
       "82     The high-affinity binding of L-noradrenaline to phenylalanine hydroxylase, as studied by equilibrium microdialysis (anaerobically) and ultrafiltration (aerobically), shows positive cooperativity (h = 1.9); at pH 7.2 and 20 degrees C the rat enzyme binds about 0.5 mol L-noradrenaline/mol subunit with a half-maximal binding (S50) at 0.25 microM L-noradrenaline.   \n",
       "5981                                                                                                                                                                                                                                                                                        Tyrosinase catalyzes an unusual oxidative decarboxylation of 3,4-dihydroxymandelate.   \n",
       "6865                                                                                                                                    Jo2-induced activation of caspase-3 or -9 in liver tissues was inhibited by minocycline pretreatment, and yet the direct addition of minocycline to liver extracts from Jo2-challenged mice failed to block caspase activation in vitro.   \n",
       "9540                                                                                                                                                                                                                   Lintitript markedly increased postprandial plasma CCK release (P<0.001) while distinctly reducing postprandial PP levels (P<0.01) as compared to placebo.   \n",
       "13166               Progestin induction of the cyclin D1 gene, which lacks a progesterone response element, was dependent on PR activation of the Src/MAPK pathway, whereas induction of the Sgk (serum and glucocorticoid regulated kinase) gene that contains a functional progesterone response element was unaffected by mutations that interfere with PR activation of Src.   \n",
       "15588                                                                                                                                                                                                  Exploring the effect of N-substitution in nor-lobelane on the interaction with VMAT2: discovery of a potential clinical candidate for treatment of methamphetamine abuse.   \n",
       "2013                                                                                                                                                                                                                                     Pranlukast-induced inhibition of IL-5 mRNA expression was noted in various cells, irrespective of their CysLTR1 mRNA expression status.   \n",
       "4064                                                                                                                                                                                                          Among the isolated compounds, trans-dihydromorin (8), oxyresveratrol (9), and steppogenin (12) were found to exhibit significant tyrosinase inhibition activities.   \n",
       "2878                                                                                                                                                                           Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.   \n",
       "11828                          To explore the molecular basis for CPT hypersensitivity in Top2β-deficient cells, we found that upon CPT exposure, the RNA polymerase II large subunit (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2β-deficient cells.   \n",
       "14046                                                                                                                                                                                                                                                      Aspirin and metformin (an activator of AMPK) increased inhibition of mTOR and Akt, as well as autophagy in CRC cells.   \n",
       "10088                                                                             A series of studies is reviewed that assesses the relationship between cytokines released at the site of tissue injury and NSAID analgesia, and the in vivo selectivity of a selective cyclooxygenase (COX)-2 inhibitor (celecoxib) in comparison to a dual COX-1/COX-2 inhibitor (ketorolac).   \n",
       "14461                                                                                                      Loss of agonist binding was observed on intact human embryonic kidney 293 cells expressing the W203A receptor, conditions where high GTP levels are present; however, high affinity binding [(3)H]PGE(2) was observed in broken cell preparations washed free of GTP.   \n",
       "5908                                                                                                                                                                Absorbable drugs (fibric acids, nicotinic acid, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or low-density lipoproteins (LDL) by a variety of mechanisms.   \n",
       "1499                                                                                                                                                                                                                        Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.   \n",
       "4491                                                                                                                               The hemoglobin A1c (HbA1c) of all patients improved significantly from 8.1±1.2% to 7.6±1.1% after 12 weeks of add-on therapy with sitagliptin (p<0.01), and the insulin dosage was reduced from 27.3±15.8 U/day to 24.5±16.5 U/day (p<0.001).   \n",
       "9342                                                                                                                                                  The relative potency of compounds in displacing [3H]-kainate binding to EAA3a receptor was: domoate > kainate > L-glutamate = quisqualate > 6,7-dinitroquinoxaline-2,3-dione (DNQX) = CNQX > AMPA > dihydrokainate > NMDA.   \n",
       "13752                                                                                                                                                                                                   The L-type calcium channel (LTCC) isoforms Ca(v)1.2 and Ca(v)1.3 display similar 1,4-dihydropyridine (DHP) binding properties and are both expressed in mammalian brain.   \n",
       "6466                                                                                                                                                                                 Pemetrexed disodium (Alimta, LY231514) is a novel, multitargeted antifolate that inhibits thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyl transferase.   \n",
       "2721                                                                                                                                                                                                   Cisapride was found to bind the human ether-a-go-go-related gene (HERG) potassium channel, which provides a plausible mechanism for QTc interval prolongation/arrhythmia.   \n",
       "12577                                                                                                                                                              This cDNA clone, designated EAA3a, shares a 90% nucleotide identity with the previously reported rat GluR5-2b cDNA splice variant and differed from human GluR5-1d in the amino and carboxy terminal regions.   \n",
       "4294                                                                                       Uptake of the radiolabeled model substrates estradiol 17β-glucuronide, estrone 3-sulfate, and dehydroepiandrosterone sulfate (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either OATP1B1 or OATP1B3.   \n",
       "1604                                                                                                                                                                                                                    5-(N,N-dimethyl)-amiloride (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.   \n",
       "11794                                                                                                                                              Fisetin treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and IL-1β (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.   \n",
       "3035                                                                                                                                                        PGE(2) is synthesized from arachidonic acid by cyclooxygenases (COX) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).   \n",
       "\n",
       "       labels                                                    entity1  \\\n",
       "10305       3                                                       PDE5   \n",
       "8422        8                                                       P-gp   \n",
       "8486        3                                                      IL-12   \n",
       "6254        1                                 norepinephrine transporter   \n",
       "1801        3                           Epidermal growth factor receptor   \n",
       "82          1                                  phenylalanine hydroxylase   \n",
       "5981        8                                                 Tyrosinase   \n",
       "6865        9                                                    caspase   \n",
       "9540        2                                                        CCK   \n",
       "13166       1                                                        Sgk   \n",
       "15588       1                                                      VMAT2   \n",
       "2013        3                                                       IL-5   \n",
       "4064        3                                                 tyrosinase   \n",
       "2878        3                                     dipeptidyl peptidase-4   \n",
       "11828       3                            RNA polymerase II large subunit   \n",
       "14046       2                                                       AMPK   \n",
       "10088       3                                                      COX-2   \n",
       "14461       1                                                      W203A   \n",
       "5908        3                                                       VLDL   \n",
       "1499        3                                                        Bad   \n",
       "4491        2                                                      HbA1c   \n",
       "9342        1                                                      EAA3a   \n",
       "13752       1                                     L-type calcium channel   \n",
       "6466        3              glycinamide ribonucleotide formyl transferase   \n",
       "2721        1  human ether-a-go-go-related gene (HERG) potassium channel   \n",
       "12577       0                                             human GluR5-1d   \n",
       "4294        8                                                    OATP1B1   \n",
       "1604        3                                                       NHE2   \n",
       "11794       3                                    glycosylated hemoglobin   \n",
       "3035        1                                 prostanoid receptors EP(1)   \n",
       "\n",
       "                              entity2       span1       span2  \\\n",
       "10305                      sildenafil    [24, 28]  [108, 118]   \n",
       "8422                       paclitaxel  [153, 157]    [83, 93]   \n",
       "8486                          JWH-210  [203, 208]  [147, 154]   \n",
       "6254                   chlorpromazine  [182, 208]  [210, 224]   \n",
       "1801                          Tarceva     [0, 32]  [144, 151]   \n",
       "82                    L-noradrenaline    [48, 73]  [268, 283]   \n",
       "5981           3,4-dihydroxymandelate     [0, 10]    [61, 83]   \n",
       "6865                      minocycline  [204, 211]  [133, 144]   \n",
       "9540                       Lintitript    [50, 53]     [0, 10]   \n",
       "13166                       Progestin  [169, 172]      [0, 9]   \n",
       "15588                               N    [79, 84]    [24, 25]   \n",
       "2013                       Pranlukast    [33, 37]     [0, 10]   \n",
       "4064               trans-dihydromorin  [129, 139]    [30, 48]   \n",
       "2878                      sitagliptin    [27, 49]    [61, 72]   \n",
       "11828                             CPT  [119, 150]  [101, 104]   \n",
       "14046                       metformin    [39, 43]    [12, 21]   \n",
       "10088                       ketorolac  [258, 263]  [275, 284]   \n",
       "14461                    [(3)H]PGE(2)   [95, 100]  [188, 200]   \n",
       "5908                         probucol  [133, 137]    [48, 56]   \n",
       "1499                 Sulindac sulfide  [116, 119]     [0, 16]   \n",
       "4491                      sitagliptin    [20, 25]  [130, 141]   \n",
       "9342                             AMPA    [72, 77]  [189, 193]   \n",
       "13752             1,4-dihydropyridine     [4, 26]   [81, 100]   \n",
       "6466                         LY231514  [141, 186]    [29, 37]   \n",
       "2721                        Cisapride    [32, 89]      [0, 9]   \n",
       "12577                           amino  [148, 162]  [170, 175]   \n",
       "4294   dehydroepiandrosterone sulfate  [258, 265]   [94, 124]   \n",
       "1604       5-(N,N-dimethyl)-amiloride  [113, 117]     [0, 26]   \n",
       "11794                         Fisetin   [79, 102]      [0, 7]   \n",
       "3035                           PGE(2)  [171, 197]      [0, 6]   \n",
       "\n",
       "                                                                                                    weak_labels  \n",
       "10305   [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "8422    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1, -1, -1]  \n",
       "8486     [-1, -1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "6254    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1, -1]  \n",
       "1801    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "82       [-1, -1, -1, 1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "5981    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1]  \n",
       "6865      [-1, -1, -1, -1, -1, -1, 2, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "9540     [-1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "13166     [-1, -1, 0, -1, -1, -1, 2, -1, 2, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "15588   [-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "2013      [-1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 9]  \n",
       "4064    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "2878    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "11828  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "14046     [-1, -1, -1, -1, -1, -1, 2, 2, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "10088   [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "14461     [-1, -1, -1, 1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 4, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "5908     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "1499     [-1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "4491    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "9342    [-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "13752   [-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "6466     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "2721    [-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "12577  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "4294    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1, -1, -1]  \n",
       "1604     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 9]  \n",
       "11794  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  \n",
       "3035    [-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]  "
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# show the first row of the dataframe\n",
    "train_dev = train_df.head(30)\n",
    "train_dev"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>labels</th>\n",
       "      <th>entity1</th>\n",
       "      <th>entity2</th>\n",
       "      <th>span1</th>\n",
       "      <th>span2</th>\n",
       "      <th>weak_labels</th>\n",
       "      <th>entity1_index</th>\n",
       "      <th>entity2_index</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>10305</th>\n",
       "      <td>Selective inhibition of PDE5 is a rational therapeutic approach in ED, as proved by the clinical success of sildenafil.</td>\n",
       "      <td>3</td>\n",
       "      <td>PDE5</td>\n",
       "      <td>sildenafil</td>\n",
       "      <td>[24, 28]</td>\n",
       "      <td>[108, 118]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>3.0</td>\n",
       "      <td>18.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8422</th>\n",
       "      <td>Furthermore, knockdown of OPN enhanced cell death caused by other drugs, including paclitaxel, doxorubicin, actinomycin-D, and rapamycin, which are also P-gp substrates.</td>\n",
       "      <td>8</td>\n",
       "      <td>P-gp</td>\n",
       "      <td>paclitaxel</td>\n",
       "      <td>[153, 157]</td>\n",
       "      <td>[83, 93]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1, -1, -1]</td>\n",
       "      <td>20.0</td>\n",
       "      <td>12.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8486</th>\n",
       "      <td>Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFα levels) was seen in LPS-stimulated human PBMCs, except with JWH-210 and JWH-122 which caused a decrease of TNFα and IL-12/23p40.</td>\n",
       "      <td>3</td>\n",
       "      <td>IL-12</td>\n",
       "      <td>JWH-210</td>\n",
       "      <td>[203, 208]</td>\n",
       "      <td>[147, 154]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>32.0</td>\n",
       "      <td>22.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6254</th>\n",
       "      <td>Among neuroleptics, the four most potent compounds at the human serotonin transporter were triflupromazine, fluperlapine, chlorpromazine, and ziprasidone (K(D) 24-39 nM); and at the norepinephrine transporter, chlorpromazine, zotepine, chlorprothixene, and promazine (K(D) 19-25 nM).</td>\n",
       "      <td>1</td>\n",
       "      <td>norepinephrine transporter</td>\n",
       "      <td>chlorpromazine</td>\n",
       "      <td>[182, 208]</td>\n",
       "      <td>[210, 224]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1, -1]</td>\n",
       "      <td>24.5</td>\n",
       "      <td>26.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1801</th>\n",
       "      <td>Epidermal growth factor receptor inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux).</td>\n",
       "      <td>3</td>\n",
       "      <td>Epidermal growth factor receptor</td>\n",
       "      <td>Tarceva</td>\n",
       "      <td>[0, 32]</td>\n",
       "      <td>[144, 151]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>1.5</td>\n",
       "      <td>17.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>The high-affinity binding of L-noradrenaline to phenylalanine hydroxylase, as studied by equilibrium microdialysis (anaerobically) and ultrafiltration (aerobically), shows positive cooperativity (h = 1.9); at pH 7.2 and 20 degrees C the rat enzyme binds about 0.5 mol L-noradrenaline/mol subunit with a half-maximal binding (S50) at 0.25 microM L-noradrenaline.</td>\n",
       "      <td>1</td>\n",
       "      <td>phenylalanine hydroxylase</td>\n",
       "      <td>L-noradrenaline</td>\n",
       "      <td>[48, 73]</td>\n",
       "      <td>[268, 283]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>6.5</td>\n",
       "      <td>37.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5981</th>\n",
       "      <td>Tyrosinase catalyzes an unusual oxidative decarboxylation of 3,4-dihydroxymandelate.</td>\n",
       "      <td>8</td>\n",
       "      <td>Tyrosinase</td>\n",
       "      <td>3,4-dihydroxymandelate</td>\n",
       "      <td>[0, 10]</td>\n",
       "      <td>[61, 83]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1]</td>\n",
       "      <td>0.0</td>\n",
       "      <td>7.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6865</th>\n",
       "      <td>Jo2-induced activation of caspase-3 or -9 in liver tissues was inhibited by minocycline pretreatment, and yet the direct addition of minocycline to liver extracts from Jo2-challenged mice failed to block caspase activation in vitro.</td>\n",
       "      <td>9</td>\n",
       "      <td>caspase</td>\n",
       "      <td>minocycline</td>\n",
       "      <td>[204, 211]</td>\n",
       "      <td>[133, 144]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, 2, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>30.0</td>\n",
       "      <td>20.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9540</th>\n",
       "      <td>Lintitript markedly increased postprandial plasma CCK release (P&lt;0.001) while distinctly reducing postprandial PP levels (P&lt;0.01) as compared to placebo.</td>\n",
       "      <td>2</td>\n",
       "      <td>CCK</td>\n",
       "      <td>Lintitript</td>\n",
       "      <td>[50, 53]</td>\n",
       "      <td>[0, 10]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>5.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13166</th>\n",
       "      <td>Progestin induction of the cyclin D1 gene, which lacks a progesterone response element, was dependent on PR activation of the Src/MAPK pathway, whereas induction of the Sgk (serum and glucocorticoid regulated kinase) gene that contains a functional progesterone response element was unaffected by mutations that interfere with PR activation of Src.</td>\n",
       "      <td>1</td>\n",
       "      <td>Sgk</td>\n",
       "      <td>Progestin</td>\n",
       "      <td>[169, 172]</td>\n",
       "      <td>[0, 9]</td>\n",
       "      <td>[-1, -1, 0, -1, -1, -1, 2, -1, 2, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>26.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15588</th>\n",
       "      <td>Exploring the effect of N-substitution in nor-lobelane on the interaction with VMAT2: discovery of a potential clinical candidate for treatment of methamphetamine abuse.</td>\n",
       "      <td>1</td>\n",
       "      <td>VMAT2</td>\n",
       "      <td>N</td>\n",
       "      <td>[79, 84]</td>\n",
       "      <td>[24, 25]</td>\n",
       "      <td>[-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>11.0</td>\n",
       "      <td>4.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2013</th>\n",
       "      <td>Pranlukast-induced inhibition of IL-5 mRNA expression was noted in various cells, irrespective of their CysLTR1 mRNA expression status.</td>\n",
       "      <td>3</td>\n",
       "      <td>IL-5</td>\n",
       "      <td>Pranlukast</td>\n",
       "      <td>[33, 37]</td>\n",
       "      <td>[0, 10]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 9]</td>\n",
       "      <td>3.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4064</th>\n",
       "      <td>Among the isolated compounds, trans-dihydromorin (8), oxyresveratrol (9), and steppogenin (12) were found to exhibit significant tyrosinase inhibition activities.</td>\n",
       "      <td>3</td>\n",
       "      <td>tyrosinase</td>\n",
       "      <td>trans-dihydromorin</td>\n",
       "      <td>[129, 139]</td>\n",
       "      <td>[30, 48]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>16.0</td>\n",
       "      <td>4.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2878</th>\n",
       "      <td>Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.</td>\n",
       "      <td>3</td>\n",
       "      <td>dipeptidyl peptidase-4</td>\n",
       "      <td>sitagliptin</td>\n",
       "      <td>[27, 49]</td>\n",
       "      <td>[61, 72]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>5.5</td>\n",
       "      <td>8.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11828</th>\n",
       "      <td>To explore the molecular basis for CPT hypersensitivity in Top2β-deficient cells, we found that upon CPT exposure, the RNA polymerase II large subunit (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2β-deficient cells.</td>\n",
       "      <td>3</td>\n",
       "      <td>RNA polymerase II large subunit</td>\n",
       "      <td>CPT</td>\n",
       "      <td>[119, 150]</td>\n",
       "      <td>[101, 104]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>20.0</td>\n",
       "      <td>15.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14046</th>\n",
       "      <td>Aspirin and metformin (an activator of AMPK) increased inhibition of mTOR and Akt, as well as autophagy in CRC cells.</td>\n",
       "      <td>2</td>\n",
       "      <td>AMPK</td>\n",
       "      <td>metformin</td>\n",
       "      <td>[39, 43]</td>\n",
       "      <td>[12, 21]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, 2, 2, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>6.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10088</th>\n",
       "      <td>A series of studies is reviewed that assesses the relationship between cytokines released at the site of tissue injury and NSAID analgesia, and the in vivo selectivity of a selective cyclooxygenase (COX)-2 inhibitor (celecoxib) in comparison to a dual COX-1/COX-2 inhibitor (ketorolac).</td>\n",
       "      <td>3</td>\n",
       "      <td>COX-2</td>\n",
       "      <td>ketorolac</td>\n",
       "      <td>[258, 263]</td>\n",
       "      <td>[275, 284]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>39.0</td>\n",
       "      <td>41.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14461</th>\n",
       "      <td>Loss of agonist binding was observed on intact human embryonic kidney 293 cells expressing the W203A receptor, conditions where high GTP levels are present; however, high affinity binding [(3)H]PGE(2) was observed in broken cell preparations washed free of GTP.</td>\n",
       "      <td>1</td>\n",
       "      <td>W203A</td>\n",
       "      <td>[(3)H]PGE(2)</td>\n",
       "      <td>[95, 100]</td>\n",
       "      <td>[188, 200]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 4, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>15.0</td>\n",
       "      <td>28.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5908</th>\n",
       "      <td>Absorbable drugs (fibric acids, nicotinic acid, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or low-density lipoproteins (LDL) by a variety of mechanisms.</td>\n",
       "      <td>3</td>\n",
       "      <td>VLDL</td>\n",
       "      <td>probucol</td>\n",
       "      <td>[133, 137]</td>\n",
       "      <td>[48, 56]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>14.0</td>\n",
       "      <td>6.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1499</th>\n",
       "      <td>Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.</td>\n",
       "      <td>3</td>\n",
       "      <td>Bad</td>\n",
       "      <td>Sulindac sulfide</td>\n",
       "      <td>[116, 119]</td>\n",
       "      <td>[0, 16]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>12.0</td>\n",
       "      <td>0.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4491</th>\n",
       "      <td>The hemoglobin A1c (HbA1c) of all patients improved significantly from 8.1±1.2% to 7.6±1.1% after 12 weeks of add-on therapy with sitagliptin (p&lt;0.01), and the insulin dosage was reduced from 27.3±15.8 U/day to 24.5±16.5 U/day (p&lt;0.001).</td>\n",
       "      <td>2</td>\n",
       "      <td>HbA1c</td>\n",
       "      <td>sitagliptin</td>\n",
       "      <td>[20, 25]</td>\n",
       "      <td>[130, 141]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>3.0</td>\n",
       "      <td>20.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9342</th>\n",
       "      <td>The relative potency of compounds in displacing [3H]-kainate binding to EAA3a receptor was: domoate &gt; kainate &gt; L-glutamate = quisqualate &gt; 6,7-dinitroquinoxaline-2,3-dione (DNQX) = CNQX &gt; AMPA &gt; dihydrokainate &gt; NMDA.</td>\n",
       "      <td>1</td>\n",
       "      <td>EAA3a</td>\n",
       "      <td>AMPA</td>\n",
       "      <td>[72, 77]</td>\n",
       "      <td>[189, 193]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>10.0</td>\n",
       "      <td>26.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13752</th>\n",
       "      <td>The L-type calcium channel (LTCC) isoforms Ca(v)1.2 and Ca(v)1.3 display similar 1,4-dihydropyridine (DHP) binding properties and are both expressed in mammalian brain.</td>\n",
       "      <td>1</td>\n",
       "      <td>L-type calcium channel</td>\n",
       "      <td>1,4-dihydropyridine</td>\n",
       "      <td>[4, 26]</td>\n",
       "      <td>[81, 100]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>2.0</td>\n",
       "      <td>11.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6466</th>\n",
       "      <td>Pemetrexed disodium (Alimta, LY231514) is a novel, multitargeted antifolate that inhibits thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyl transferase.</td>\n",
       "      <td>3</td>\n",
       "      <td>glycinamide ribonucleotide formyl transferase</td>\n",
       "      <td>LY231514</td>\n",
       "      <td>[141, 186]</td>\n",
       "      <td>[29, 37]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>17.5</td>\n",
       "      <td>3.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2721</th>\n",
       "      <td>Cisapride was found to bind the human ether-a-go-go-related gene (HERG) potassium channel, which provides a plausible mechanism for QTc interval prolongation/arrhythmia.</td>\n",
       "      <td>1</td>\n",
       "      <td>human ether-a-go-go-related gene (HERG) potassium channel</td>\n",
       "      <td>Cisapride</td>\n",
       "      <td>[32, 89]</td>\n",
       "      <td>[0, 9]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>8.5</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12577</th>\n",
       "      <td>This cDNA clone, designated EAA3a, shares a 90% nucleotide identity with the previously reported rat GluR5-2b cDNA splice variant and differed from human GluR5-1d in the amino and carboxy terminal regions.</td>\n",
       "      <td>0</td>\n",
       "      <td>human GluR5-1d</td>\n",
       "      <td>amino</td>\n",
       "      <td>[148, 162]</td>\n",
       "      <td>[170, 175]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>22.5</td>\n",
       "      <td>26.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4294</th>\n",
       "      <td>Uptake of the radiolabeled model substrates estradiol 17β-glucuronide, estrone 3-sulfate, and dehydroepiandrosterone sulfate (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either OATP1B1 or OATP1B3.</td>\n",
       "      <td>8</td>\n",
       "      <td>OATP1B1</td>\n",
       "      <td>dehydroepiandrosterone sulfate</td>\n",
       "      <td>[258, 265]</td>\n",
       "      <td>[94, 124]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1, -1, -1]</td>\n",
       "      <td>33.0</td>\n",
       "      <td>11.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1604</th>\n",
       "      <td>5-(N,N-dimethyl)-amiloride (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.</td>\n",
       "      <td>3</td>\n",
       "      <td>NHE2</td>\n",
       "      <td>5-(N,N-dimethyl)-amiloride</td>\n",
       "      <td>[113, 117]</td>\n",
       "      <td>[0, 26]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 9]</td>\n",
       "      <td>14.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11794</th>\n",
       "      <td>Fisetin treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and IL-1β (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.</td>\n",
       "      <td>3</td>\n",
       "      <td>glycosylated hemoglobin</td>\n",
       "      <td>Fisetin</td>\n",
       "      <td>[79, 102]</td>\n",
       "      <td>[0, 7]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>12.5</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3035</th>\n",
       "      <td>PGE(2) is synthesized from arachidonic acid by cyclooxygenases (COX) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).</td>\n",
       "      <td>1</td>\n",
       "      <td>prostanoid receptors EP(1)</td>\n",
       "      <td>PGE(2)</td>\n",
       "      <td>[171, 197]</td>\n",
       "      <td>[0, 6]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>25.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                            text  \\\n",
       "10305                                                                                                                                                                                                                                                    Selective inhibition of PDE5 is a rational therapeutic approach in ED, as proved by the clinical success of sildenafil.   \n",
       "8422                                                                                                                                                                                                   Furthermore, knockdown of OPN enhanced cell death caused by other drugs, including paclitaxel, doxorubicin, actinomycin-D, and rapamycin, which are also P-gp substrates.   \n",
       "8486                                                                                                                                                     Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFα levels) was seen in LPS-stimulated human PBMCs, except with JWH-210 and JWH-122 which caused a decrease of TNFα and IL-12/23p40.   \n",
       "6254                                                                                 Among neuroleptics, the four most potent compounds at the human serotonin transporter were triflupromazine, fluperlapine, chlorpromazine, and ziprasidone (K(D) 24-39 nM); and at the norepinephrine transporter, chlorpromazine, zotepine, chlorprothixene, and promazine (K(D) 19-25 nM).   \n",
       "1801                                                                                                                                   Epidermal growth factor receptor inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux).   \n",
       "82     The high-affinity binding of L-noradrenaline to phenylalanine hydroxylase, as studied by equilibrium microdialysis (anaerobically) and ultrafiltration (aerobically), shows positive cooperativity (h = 1.9); at pH 7.2 and 20 degrees C the rat enzyme binds about 0.5 mol L-noradrenaline/mol subunit with a half-maximal binding (S50) at 0.25 microM L-noradrenaline.   \n",
       "5981                                                                                                                                                                                                                                                                                        Tyrosinase catalyzes an unusual oxidative decarboxylation of 3,4-dihydroxymandelate.   \n",
       "6865                                                                                                                                    Jo2-induced activation of caspase-3 or -9 in liver tissues was inhibited by minocycline pretreatment, and yet the direct addition of minocycline to liver extracts from Jo2-challenged mice failed to block caspase activation in vitro.   \n",
       "9540                                                                                                                                                                                                                   Lintitript markedly increased postprandial plasma CCK release (P<0.001) while distinctly reducing postprandial PP levels (P<0.01) as compared to placebo.   \n",
       "13166               Progestin induction of the cyclin D1 gene, which lacks a progesterone response element, was dependent on PR activation of the Src/MAPK pathway, whereas induction of the Sgk (serum and glucocorticoid regulated kinase) gene that contains a functional progesterone response element was unaffected by mutations that interfere with PR activation of Src.   \n",
       "15588                                                                                                                                                                                                  Exploring the effect of N-substitution in nor-lobelane on the interaction with VMAT2: discovery of a potential clinical candidate for treatment of methamphetamine abuse.   \n",
       "2013                                                                                                                                                                                                                                     Pranlukast-induced inhibition of IL-5 mRNA expression was noted in various cells, irrespective of their CysLTR1 mRNA expression status.   \n",
       "4064                                                                                                                                                                                                          Among the isolated compounds, trans-dihydromorin (8), oxyresveratrol (9), and steppogenin (12) were found to exhibit significant tyrosinase inhibition activities.   \n",
       "2878                                                                                                                                                                           Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.   \n",
       "11828                          To explore the molecular basis for CPT hypersensitivity in Top2β-deficient cells, we found that upon CPT exposure, the RNA polymerase II large subunit (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2β-deficient cells.   \n",
       "14046                                                                                                                                                                                                                                                      Aspirin and metformin (an activator of AMPK) increased inhibition of mTOR and Akt, as well as autophagy in CRC cells.   \n",
       "10088                                                                             A series of studies is reviewed that assesses the relationship between cytokines released at the site of tissue injury and NSAID analgesia, and the in vivo selectivity of a selective cyclooxygenase (COX)-2 inhibitor (celecoxib) in comparison to a dual COX-1/COX-2 inhibitor (ketorolac).   \n",
       "14461                                                                                                      Loss of agonist binding was observed on intact human embryonic kidney 293 cells expressing the W203A receptor, conditions where high GTP levels are present; however, high affinity binding [(3)H]PGE(2) was observed in broken cell preparations washed free of GTP.   \n",
       "5908                                                                                                                                                                Absorbable drugs (fibric acids, nicotinic acid, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or low-density lipoproteins (LDL) by a variety of mechanisms.   \n",
       "1499                                                                                                                                                                                                                        Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.   \n",
       "4491                                                                                                                               The hemoglobin A1c (HbA1c) of all patients improved significantly from 8.1±1.2% to 7.6±1.1% after 12 weeks of add-on therapy with sitagliptin (p<0.01), and the insulin dosage was reduced from 27.3±15.8 U/day to 24.5±16.5 U/day (p<0.001).   \n",
       "9342                                                                                                                                                  The relative potency of compounds in displacing [3H]-kainate binding to EAA3a receptor was: domoate > kainate > L-glutamate = quisqualate > 6,7-dinitroquinoxaline-2,3-dione (DNQX) = CNQX > AMPA > dihydrokainate > NMDA.   \n",
       "13752                                                                                                                                                                                                   The L-type calcium channel (LTCC) isoforms Ca(v)1.2 and Ca(v)1.3 display similar 1,4-dihydropyridine (DHP) binding properties and are both expressed in mammalian brain.   \n",
       "6466                                                                                                                                                                                 Pemetrexed disodium (Alimta, LY231514) is a novel, multitargeted antifolate that inhibits thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyl transferase.   \n",
       "2721                                                                                                                                                                                                   Cisapride was found to bind the human ether-a-go-go-related gene (HERG) potassium channel, which provides a plausible mechanism for QTc interval prolongation/arrhythmia.   \n",
       "12577                                                                                                                                                              This cDNA clone, designated EAA3a, shares a 90% nucleotide identity with the previously reported rat GluR5-2b cDNA splice variant and differed from human GluR5-1d in the amino and carboxy terminal regions.   \n",
       "4294                                                                                       Uptake of the radiolabeled model substrates estradiol 17β-glucuronide, estrone 3-sulfate, and dehydroepiandrosterone sulfate (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either OATP1B1 or OATP1B3.   \n",
       "1604                                                                                                                                                                                                                    5-(N,N-dimethyl)-amiloride (50 microM; DMA), a concentration that selectively inhibits the NHE isoforms NHE1 and NHE2, but not NHE3, did not affect DBS.   \n",
       "11794                                                                                                                                              Fisetin treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and IL-1β (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.   \n",
       "3035                                                                                                                                                        PGE(2) is synthesized from arachidonic acid by cyclooxygenases (COX) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).   \n",
       "\n",
       "       labels                                                    entity1  \\\n",
       "10305       3                                                       PDE5   \n",
       "8422        8                                                       P-gp   \n",
       "8486        3                                                      IL-12   \n",
       "6254        1                                 norepinephrine transporter   \n",
       "1801        3                           Epidermal growth factor receptor   \n",
       "82          1                                  phenylalanine hydroxylase   \n",
       "5981        8                                                 Tyrosinase   \n",
       "6865        9                                                    caspase   \n",
       "9540        2                                                        CCK   \n",
       "13166       1                                                        Sgk   \n",
       "15588       1                                                      VMAT2   \n",
       "2013        3                                                       IL-5   \n",
       "4064        3                                                 tyrosinase   \n",
       "2878        3                                     dipeptidyl peptidase-4   \n",
       "11828       3                            RNA polymerase II large subunit   \n",
       "14046       2                                                       AMPK   \n",
       "10088       3                                                      COX-2   \n",
       "14461       1                                                      W203A   \n",
       "5908        3                                                       VLDL   \n",
       "1499        3                                                        Bad   \n",
       "4491        2                                                      HbA1c   \n",
       "9342        1                                                      EAA3a   \n",
       "13752       1                                     L-type calcium channel   \n",
       "6466        3              glycinamide ribonucleotide formyl transferase   \n",
       "2721        1  human ether-a-go-go-related gene (HERG) potassium channel   \n",
       "12577       0                                             human GluR5-1d   \n",
       "4294        8                                                    OATP1B1   \n",
       "1604        3                                                       NHE2   \n",
       "11794       3                                    glycosylated hemoglobin   \n",
       "3035        1                                 prostanoid receptors EP(1)   \n",
       "\n",
       "                              entity2       span1       span2  \\\n",
       "10305                      sildenafil    [24, 28]  [108, 118]   \n",
       "8422                       paclitaxel  [153, 157]    [83, 93]   \n",
       "8486                          JWH-210  [203, 208]  [147, 154]   \n",
       "6254                   chlorpromazine  [182, 208]  [210, 224]   \n",
       "1801                          Tarceva     [0, 32]  [144, 151]   \n",
       "82                    L-noradrenaline    [48, 73]  [268, 283]   \n",
       "5981           3,4-dihydroxymandelate     [0, 10]    [61, 83]   \n",
       "6865                      minocycline  [204, 211]  [133, 144]   \n",
       "9540                       Lintitript    [50, 53]     [0, 10]   \n",
       "13166                       Progestin  [169, 172]      [0, 9]   \n",
       "15588                               N    [79, 84]    [24, 25]   \n",
       "2013                       Pranlukast    [33, 37]     [0, 10]   \n",
       "4064               trans-dihydromorin  [129, 139]    [30, 48]   \n",
       "2878                      sitagliptin    [27, 49]    [61, 72]   \n",
       "11828                             CPT  [119, 150]  [101, 104]   \n",
       "14046                       metformin    [39, 43]    [12, 21]   \n",
       "10088                       ketorolac  [258, 263]  [275, 284]   \n",
       "14461                    [(3)H]PGE(2)   [95, 100]  [188, 200]   \n",
       "5908                         probucol  [133, 137]    [48, 56]   \n",
       "1499                 Sulindac sulfide  [116, 119]     [0, 16]   \n",
       "4491                      sitagliptin    [20, 25]  [130, 141]   \n",
       "9342                             AMPA    [72, 77]  [189, 193]   \n",
       "13752             1,4-dihydropyridine     [4, 26]   [81, 100]   \n",
       "6466                         LY231514  [141, 186]    [29, 37]   \n",
       "2721                        Cisapride    [32, 89]      [0, 9]   \n",
       "12577                           amino  [148, 162]  [170, 175]   \n",
       "4294   dehydroepiandrosterone sulfate  [258, 265]   [94, 124]   \n",
       "1604       5-(N,N-dimethyl)-amiloride  [113, 117]     [0, 26]   \n",
       "11794                         Fisetin   [79, 102]      [0, 7]   \n",
       "3035                           PGE(2)  [171, 197]      [0, 6]   \n",
       "\n",
       "                                                                                                    weak_labels  \\\n",
       "10305   [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "8422    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1, -1, -1]   \n",
       "8486     [-1, -1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "6254    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1, -1]   \n",
       "1801    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "82       [-1, -1, -1, 1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "5981    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1]   \n",
       "6865      [-1, -1, -1, -1, -1, -1, 2, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "9540     [-1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "13166     [-1, -1, 0, -1, -1, -1, 2, -1, 2, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "15588   [-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "2013      [-1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 9]   \n",
       "4064    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "2878    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "11828  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "14046     [-1, -1, -1, -1, -1, -1, 2, 2, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "10088   [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "14461     [-1, -1, -1, 1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 4, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "5908     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "1499     [-1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "4491    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "9342    [-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "13752   [-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "6466     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "2721    [-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "12577  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "4294    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1, -1, -1, -1, -1]   \n",
       "1604     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 9]   \n",
       "11794  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "3035    [-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "\n",
       "       entity1_index  entity2_index  \n",
       "10305            3.0           18.0  \n",
       "8422            20.0           12.0  \n",
       "8486            32.0           22.0  \n",
       "6254            24.5           26.0  \n",
       "1801             1.5           17.0  \n",
       "82               6.5           37.0  \n",
       "5981             0.0            7.0  \n",
       "6865            30.0           20.0  \n",
       "9540             5.0            0.0  \n",
       "13166           26.0            0.0  \n",
       "15588           11.0            4.0  \n",
       "2013             3.0            0.0  \n",
       "4064            16.0            4.0  \n",
       "2878             5.5            8.0  \n",
       "11828           20.0           15.0  \n",
       "14046            6.0            2.0  \n",
       "10088           39.0           41.0  \n",
       "14461           15.0           28.0  \n",
       "5908            14.0            6.0  \n",
       "1499            12.0            0.5  \n",
       "4491             3.0           20.0  \n",
       "9342            10.0           26.0  \n",
       "13752            2.0           11.0  \n",
       "6466            17.5            3.0  \n",
       "2721             8.5            0.0  \n",
       "12577           22.5           26.0  \n",
       "4294            33.0           11.5  \n",
       "1604            14.0            0.0  \n",
       "11794           12.5            0.0  \n",
       "3035            25.0            0.0  "
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = li.chemprot_enhanced(train_dev)\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 30/30 [00:00<00:00, 23466.83it/s]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "array([[-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1]])"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lfs = [lf_combined_modulator]\n",
    "\n",
    "# Initialize the applier\n",
    "applier = PandasLFApplier(lfs=lfs)\n",
    "L_train = applier.apply(df=df)\n",
    "L_train"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>labels</th>\n",
       "      <th>entity1</th>\n",
       "      <th>entity2</th>\n",
       "      <th>span1</th>\n",
       "      <th>span2</th>\n",
       "      <th>weak_labels</th>\n",
       "      <th>entity1_index</th>\n",
       "      <th>entity2_index</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>12446</th>\n",
       "      <td>While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s &gt;30μM) and a robust 20-fold leftward shift of the ACh CRC.</td>\n",
       "      <td>6</td>\n",
       "      <td>M5</td>\n",
       "      <td>ML172</td>\n",
       "      <td>[173, 175]</td>\n",
       "      <td>[129, 134]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>28.0</td>\n",
       "      <td>21.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3477</th>\n",
       "      <td>Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor.</td>\n",
       "      <td>6</td>\n",
       "      <td>mGlu₄</td>\n",
       "      <td>Lu AF21934</td>\n",
       "      <td>[120, 125]</td>\n",
       "      <td>[52, 62]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, 6, -1, -1, -1, -1, -1, -1, 9]</td>\n",
       "      <td>16.0</td>\n",
       "      <td>6.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8655</th>\n",
       "      <td>Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas PRA was down-regulated in the uterus and oviduct after ethanol consumption.</td>\n",
       "      <td>6</td>\n",
       "      <td>PRB</td>\n",
       "      <td>melatonin</td>\n",
       "      <td>[28, 31]</td>\n",
       "      <td>[81, 90]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1]</td>\n",
       "      <td>4.0</td>\n",
       "      <td>11.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3387</th>\n",
       "      <td>BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (L-VGCCs), which could contribute to reduced neuronal excitability.</td>\n",
       "      <td>6</td>\n",
       "      <td>GABA(A)R</td>\n",
       "      <td>BDZs</td>\n",
       "      <td>[24, 32]</td>\n",
       "      <td>[0, 4]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8654</th>\n",
       "      <td>Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas PRA was down-regulated in the uterus and oviduct after ethanol consumption.</td>\n",
       "      <td>6</td>\n",
       "      <td>PRA</td>\n",
       "      <td>melatonin</td>\n",
       "      <td>[20, 23]</td>\n",
       "      <td>[81, 90]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1]</td>\n",
       "      <td>2.0</td>\n",
       "      <td>11.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13836</th>\n",
       "      <td>The recently discovered hyperinsulinism/hyperammonemia disorder showed that the loss of allosteric inhibition of GDH by GTP causes excessive secretion of insulin.</td>\n",
       "      <td>6</td>\n",
       "      <td>GDH</td>\n",
       "      <td>GTP</td>\n",
       "      <td>[113, 116]</td>\n",
       "      <td>[120, 123]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>13.0</td>\n",
       "      <td>15.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5378</th>\n",
       "      <td>The implications of our finding for mechanism of in vivo actions of rapamycin and for design of novel allosteric drugs targeting the proteasome are discussed.</td>\n",
       "      <td>6</td>\n",
       "      <td>proteasome</td>\n",
       "      <td>rapamycin</td>\n",
       "      <td>[133, 143]</td>\n",
       "      <td>[68, 77]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>22.0</td>\n",
       "      <td>12.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3606</th>\n",
       "      <td>Ifenprodil is an allosteric inhibitor of GluN1/GluN2B N-methyl-D-aspartate receptors.</td>\n",
       "      <td>6</td>\n",
       "      <td>GluN1</td>\n",
       "      <td>Ifenprodil</td>\n",
       "      <td>[41, 46]</td>\n",
       "      <td>[0, 10]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>6.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15281</th>\n",
       "      <td>Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists.</td>\n",
       "      <td>6</td>\n",
       "      <td>CC-chemokine receptor 4</td>\n",
       "      <td>indazole arylsulfonamides</td>\n",
       "      <td>[90, 113]</td>\n",
       "      <td>[50, 75]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 5, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>10.0</td>\n",
       "      <td>5.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3381</th>\n",
       "      <td>Benzodiazepines (BDZs) depress neuronal excitability via positive allosteric modulation of inhibitory GABA(A) receptors (GABA(A)R).</td>\n",
       "      <td>6</td>\n",
       "      <td>GABA(A)R</td>\n",
       "      <td>BDZs</td>\n",
       "      <td>[121, 129]</td>\n",
       "      <td>[17, 21]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, 6, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>13.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14216</th>\n",
       "      <td>The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.</td>\n",
       "      <td>6</td>\n",
       "      <td>nAChR</td>\n",
       "      <td>eseroline</td>\n",
       "      <td>[193, 198]</td>\n",
       "      <td>[45, 54]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>25.0</td>\n",
       "      <td>6.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8650</th>\n",
       "      <td>Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas PRA was down-regulated in the uterus and oviduct after ethanol consumption.</td>\n",
       "      <td>6</td>\n",
       "      <td>PRA</td>\n",
       "      <td>ethanol</td>\n",
       "      <td>[20, 23]</td>\n",
       "      <td>[61, 68]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1]</td>\n",
       "      <td>2.0</td>\n",
       "      <td>9.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12445</th>\n",
       "      <td>While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s &gt;30μM) and a robust 20-fold leftward shift of the ACh CRC.</td>\n",
       "      <td>6</td>\n",
       "      <td>M5</td>\n",
       "      <td>ML129</td>\n",
       "      <td>[173, 175]</td>\n",
       "      <td>[123, 128]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>28.0</td>\n",
       "      <td>21.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9857</th>\n",
       "      <td>Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism.</td>\n",
       "      <td>6</td>\n",
       "      <td>ETA receptors</td>\n",
       "      <td>Aspirin</td>\n",
       "      <td>[49, 62]</td>\n",
       "      <td>[0, 7]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>6.5</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13869</th>\n",
       "      <td>Because these speeds are significantly faster than the responses to antagonists, these data indicate that gallamine and dimethyl-W84 are allosteric ligands and actively induce a conformation of the M(2) receptor with a reduced affinity for its agonists.</td>\n",
       "      <td>6</td>\n",
       "      <td>M(2) receptor</td>\n",
       "      <td>gallamine</td>\n",
       "      <td>[198, 211]</td>\n",
       "      <td>[106, 115]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, 1, -1, -1, 2, -1, -1, -1, 3, -1, -1, 4, 5, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>28.5</td>\n",
       "      <td>15.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8651</th>\n",
       "      <td>Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas PRA was down-regulated in the uterus and oviduct after ethanol consumption.</td>\n",
       "      <td>6</td>\n",
       "      <td>PRB</td>\n",
       "      <td>ethanol</td>\n",
       "      <td>[28, 31]</td>\n",
       "      <td>[61, 68]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1]</td>\n",
       "      <td>4.0</td>\n",
       "      <td>9.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5381</th>\n",
       "      <td>Rapamycin is a canonical allosteric inhibitor of the mTOR kinase with immunosuppressive and pro-apoptotic activities.</td>\n",
       "      <td>6</td>\n",
       "      <td>kinase</td>\n",
       "      <td>Rapamycin</td>\n",
       "      <td>[58, 64]</td>\n",
       "      <td>[0, 9]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>9.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12448</th>\n",
       "      <td>While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s &gt;30μM) and a robust 20-fold leftward shift of the ACh CRC.</td>\n",
       "      <td>6</td>\n",
       "      <td>M5</td>\n",
       "      <td>ML326</td>\n",
       "      <td>[215, 217]</td>\n",
       "      <td>[181, 186]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>35.0</td>\n",
       "      <td>30.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12447</th>\n",
       "      <td>While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s &gt;30μM) and a robust 20-fold leftward shift of the ACh CRC.</td>\n",
       "      <td>6</td>\n",
       "      <td>M5</td>\n",
       "      <td>ML326</td>\n",
       "      <td>[173, 175]</td>\n",
       "      <td>[181, 186]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>28.0</td>\n",
       "      <td>30.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12978</th>\n",
       "      <td>Diacylglycerol (DAG) acts as an allosteric activator of protein kinase C (PKC) and is converted to phosphatidic acid by DAG kinase (DGK).</td>\n",
       "      <td>6</td>\n",
       "      <td>PKC</td>\n",
       "      <td>DAG</td>\n",
       "      <td>[74, 77]</td>\n",
       "      <td>[16, 19]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, 8, -1]</td>\n",
       "      <td>11.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12444</th>\n",
       "      <td>While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s &gt;30μM) and a robust 20-fold leftward shift of the ACh CRC.</td>\n",
       "      <td>6</td>\n",
       "      <td>M5</td>\n",
       "      <td>phenethyl ether</td>\n",
       "      <td>[173, 175]</td>\n",
       "      <td>[90, 105]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>28.0</td>\n",
       "      <td>16.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3608</th>\n",
       "      <td>Ifenprodil is an allosteric inhibitor of GluN1/GluN2B N-methyl-D-aspartate receptors.</td>\n",
       "      <td>6</td>\n",
       "      <td>N-methyl-D-aspartate receptors</td>\n",
       "      <td>Ifenprodil</td>\n",
       "      <td>[54, 84]</td>\n",
       "      <td>[0, 10]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>7.5</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13508</th>\n",
       "      <td>Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors.</td>\n",
       "      <td>6</td>\n",
       "      <td>human muscarinic M2 receptors</td>\n",
       "      <td>vecuronium</td>\n",
       "      <td>[97, 126]</td>\n",
       "      <td>[53, 63]</td>\n",
       "      <td>[-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>12.5</td>\n",
       "      <td>6.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13506</th>\n",
       "      <td>These data indicate that vecuronium, gallamine and pancuronium interact with an allosteric site on the muscarinic M2 receptor (located on the heart) and this may explain some of their cardiac side effects.</td>\n",
       "      <td>6</td>\n",
       "      <td>muscarinic M2 receptor</td>\n",
       "      <td>gallamine</td>\n",
       "      <td>[103, 125]</td>\n",
       "      <td>[37, 46]</td>\n",
       "      <td>[-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>16.0</td>\n",
       "      <td>5.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11212</th>\n",
       "      <td>In addition to studies focused on the mechanisms of nuclear receptor function, additional work has illuminated the mechanism by which androgens are metabolized in selected tissues.</td>\n",
       "      <td>6</td>\n",
       "      <td>nuclear receptor</td>\n",
       "      <td>androgens</td>\n",
       "      <td>[52, 68]</td>\n",
       "      <td>[134, 143]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>9.5</td>\n",
       "      <td>20.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5377</th>\n",
       "      <td>We hypothesize that the rapamycin and related compounds bind to the α face and allosterically impact the proteasome function.</td>\n",
       "      <td>6</td>\n",
       "      <td>proteasome</td>\n",
       "      <td>rapamycin</td>\n",
       "      <td>[105, 115]</td>\n",
       "      <td>[24, 33]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>17.0</td>\n",
       "      <td>4.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11238</th>\n",
       "      <td>A number of agents are being developed that target molecular abnormalities in IEN, have fewer or different side effects than tamoxifen, and may be effective in ER-negative or tamoxifen-resistant disease.</td>\n",
       "      <td>6</td>\n",
       "      <td>ER</td>\n",
       "      <td>tamoxifen</td>\n",
       "      <td>[160, 162]</td>\n",
       "      <td>[125, 134]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>26.0</td>\n",
       "      <td>20.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5379</th>\n",
       "      <td>Rapamycin allosterically inhibits the proteasome.</td>\n",
       "      <td>6</td>\n",
       "      <td>proteasome</td>\n",
       "      <td>Rapamycin</td>\n",
       "      <td>[38, 48]</td>\n",
       "      <td>[0, 9]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>4.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12440</th>\n",
       "      <td>This Letter describes the further chemical optimization of the M5 PAM MLPCN probes ML129 and ML172.</td>\n",
       "      <td>6</td>\n",
       "      <td>M5</td>\n",
       "      <td>ML172</td>\n",
       "      <td>[63, 65]</td>\n",
       "      <td>[93, 98]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>9.0</td>\n",
       "      <td>15.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3478</th>\n",
       "      <td>Herein, we report the pharmacological actions of Lu AF21934, a novel, selective, and brain-penetrant positive allosteric modulator (PAM) of the mGlu(4) receptor in the stress-induced hyperthermia (SIH), four-plate, marble-burying and Vogel's conflict tests.</td>\n",
       "      <td>6</td>\n",
       "      <td>mGlu(4)</td>\n",
       "      <td>Lu AF21934</td>\n",
       "      <td>[144, 151]</td>\n",
       "      <td>[49, 59]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, -1, -1, -1, -1, 6, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>20.0</td>\n",
       "      <td>7.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9859</th>\n",
       "      <td>It is concluded that salicylates are allosteric inhibitors of ETA receptors.</td>\n",
       "      <td>6</td>\n",
       "      <td>ETA receptors</td>\n",
       "      <td>salicylates</td>\n",
       "      <td>[62, 75]</td>\n",
       "      <td>[21, 32]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>9.5</td>\n",
       "      <td>4.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4409</th>\n",
       "      <td>However, one mGlu5 PAM, CPPHA (N-(4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl)-2-hydroxybenzamide), interacts with a separate allosteric site on mGlu5.</td>\n",
       "      <td>6</td>\n",
       "      <td>mGlu5</td>\n",
       "      <td>CPPHA</td>\n",
       "      <td>[13, 18]</td>\n",
       "      <td>[24, 29]</td>\n",
       "      <td>[-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>2.0</td>\n",
       "      <td>4.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12441</th>\n",
       "      <td>Discovery of ML326: The first sub-micromolar, selective M5 PAM.</td>\n",
       "      <td>6</td>\n",
       "      <td>M5</td>\n",
       "      <td>ML326</td>\n",
       "      <td>[56, 58]</td>\n",
       "      <td>[13, 18]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>7.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3386</th>\n",
       "      <td>BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (L-VGCCs), which could contribute to reduced neuronal excitability.</td>\n",
       "      <td>6</td>\n",
       "      <td>GABA(A)R</td>\n",
       "      <td>neurosteroids</td>\n",
       "      <td>[24, 32]</td>\n",
       "      <td>[82, 95]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>4.0</td>\n",
       "      <td>10.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12437</th>\n",
       "      <td>While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s &gt;30μM) and a robust 20-fold leftward shift of the ACh CRC.</td>\n",
       "      <td>6</td>\n",
       "      <td>M5</td>\n",
       "      <td>VU0467903</td>\n",
       "      <td>[173, 175]</td>\n",
       "      <td>[188, 197]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>28.0</td>\n",
       "      <td>31.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4410</th>\n",
       "      <td>However, one mGlu5 PAM, CPPHA (N-(4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl)-2-hydroxybenzamide), interacts with a separate allosteric site on mGlu5.</td>\n",
       "      <td>6</td>\n",
       "      <td>mGlu5</td>\n",
       "      <td>N-(4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl)-2-hydroxybenzamide</td>\n",
       "      <td>[13, 18]</td>\n",
       "      <td>[31, 119]</td>\n",
       "      <td>[-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>2.0</td>\n",
       "      <td>5.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3383</th>\n",
       "      <td>Benzodiazepines (BDZs) depress neuronal excitability via positive allosteric modulation of inhibitory GABA(A) receptors (GABA(A)R).</td>\n",
       "      <td>6</td>\n",
       "      <td>GABA(A)R</td>\n",
       "      <td>Benzodiazepines</td>\n",
       "      <td>[121, 129]</td>\n",
       "      <td>[0, 15]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, 6, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>13.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14215</th>\n",
       "      <td>The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.</td>\n",
       "      <td>6</td>\n",
       "      <td>nAChR</td>\n",
       "      <td>eseroline</td>\n",
       "      <td>[83, 88]</td>\n",
       "      <td>[45, 54]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>11.0</td>\n",
       "      <td>6.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1136</th>\n",
       "      <td>A great deal of information has now accumulated pertaining to the mechanisms by which nuclear receptors, such as the androgen receptor, modulate the activity of responsive genes.</td>\n",
       "      <td>6</td>\n",
       "      <td>nuclear receptors</td>\n",
       "      <td>androgen</td>\n",
       "      <td>[86, 103]</td>\n",
       "      <td>[117, 125]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>14.5</td>\n",
       "      <td>19.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4413</th>\n",
       "      <td>Using cell-based assays and brain slice preparations, we characterized the interaction of a potent and efficacious mGlu5 PAM from the CPPHA series termed NCFP (N-(4-chloro-2-((4-fluoro-1,3-dioxoisoindolin-2-yl)methyl)phenyl)picolinamide).</td>\n",
       "      <td>6</td>\n",
       "      <td>mGlu5</td>\n",
       "      <td>N-(4-chloro-2-((4-fluoro-1,3-dioxoisoindolin-2-yl)methyl)phenyl)picolinamide</td>\n",
       "      <td>[115, 120]</td>\n",
       "      <td>[160, 236]</td>\n",
       "      <td>[-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>16.0</td>\n",
       "      <td>24.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3385</th>\n",
       "      <td>BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (L-VGCCs), which could contribute to reduced neuronal excitability.</td>\n",
       "      <td>6</td>\n",
       "      <td>GABA(A)R</td>\n",
       "      <td>ethanol</td>\n",
       "      <td>[24, 32]</td>\n",
       "      <td>[69, 76]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>4.0</td>\n",
       "      <td>8.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3382</th>\n",
       "      <td>Benzodiazepines (BDZs) depress neuronal excitability via positive allosteric modulation of inhibitory GABA(A) receptors (GABA(A)R).</td>\n",
       "      <td>6</td>\n",
       "      <td>GABA(A) receptors</td>\n",
       "      <td>Benzodiazepines</td>\n",
       "      <td>[102, 119]</td>\n",
       "      <td>[0, 15]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, 6, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>11.5</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4411</th>\n",
       "      <td>Using cell-based assays and brain slice preparations, we characterized the interaction of a potent and efficacious mGlu5 PAM from the CPPHA series termed NCFP (N-(4-chloro-2-((4-fluoro-1,3-dioxoisoindolin-2-yl)methyl)phenyl)picolinamide).</td>\n",
       "      <td>6</td>\n",
       "      <td>mGlu5</td>\n",
       "      <td>CPPHA</td>\n",
       "      <td>[115, 120]</td>\n",
       "      <td>[134, 139]</td>\n",
       "      <td>[-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>16.0</td>\n",
       "      <td>20.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12977</th>\n",
       "      <td>Diacylglycerol (DAG) acts as an allosteric activator of protein kinase C (PKC) and is converted to phosphatidic acid by DAG kinase (DGK).</td>\n",
       "      <td>6</td>\n",
       "      <td>protein kinase C</td>\n",
       "      <td>DAG</td>\n",
       "      <td>[56, 72]</td>\n",
       "      <td>[16, 19]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, 8, -1]</td>\n",
       "      <td>9.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14214</th>\n",
       "      <td>The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.</td>\n",
       "      <td>6</td>\n",
       "      <td>nAChR</td>\n",
       "      <td>codeine</td>\n",
       "      <td>[193, 198]</td>\n",
       "      <td>[33, 40]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>25.0</td>\n",
       "      <td>4.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12976</th>\n",
       "      <td>Diacylglycerol (DAG) acts as an allosteric activator of protein kinase C (PKC) and is converted to phosphatidic acid by DAG kinase (DGK).</td>\n",
       "      <td>6</td>\n",
       "      <td>PKC</td>\n",
       "      <td>Diacylglycerol</td>\n",
       "      <td>[74, 77]</td>\n",
       "      <td>[0, 14]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, 8, -1]</td>\n",
       "      <td>11.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8652</th>\n",
       "      <td>Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas PRA was down-regulated in the uterus and oviduct after ethanol consumption.</td>\n",
       "      <td>6</td>\n",
       "      <td>PRA</td>\n",
       "      <td>ethanol</td>\n",
       "      <td>[20, 23]</td>\n",
       "      <td>[73, 80]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1]</td>\n",
       "      <td>2.0</td>\n",
       "      <td>11.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4425</th>\n",
       "      <td>Evidence for a new binding mode to GSK-3: allosteric regulation by the marine compound palinurin.</td>\n",
       "      <td>6</td>\n",
       "      <td>GSK-3</td>\n",
       "      <td>palinurin</td>\n",
       "      <td>[35, 40]</td>\n",
       "      <td>[87, 96]</td>\n",
       "      <td>[-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>7.0</td>\n",
       "      <td>14.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14213</th>\n",
       "      <td>The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.</td>\n",
       "      <td>6</td>\n",
       "      <td>nAChR</td>\n",
       "      <td>codeine</td>\n",
       "      <td>[83, 88]</td>\n",
       "      <td>[33, 40]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>11.0</td>\n",
       "      <td>4.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3763</th>\n",
       "      <td>Hydrogen sulfide as an allosteric modulator of ATP-sensitive potassium channels in colonic inflammation.</td>\n",
       "      <td>6</td>\n",
       "      <td>ATP-sensitive potassium channels</td>\n",
       "      <td>Hydrogen sulfide</td>\n",
       "      <td>[47, 79]</td>\n",
       "      <td>[0, 16]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>8.0</td>\n",
       "      <td>0.5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3607</th>\n",
       "      <td>Ifenprodil is an allosteric inhibitor of GluN1/GluN2B N-methyl-D-aspartate receptors.</td>\n",
       "      <td>6</td>\n",
       "      <td>GluN2B</td>\n",
       "      <td>Ifenprodil</td>\n",
       "      <td>[47, 53]</td>\n",
       "      <td>[0, 10]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>6.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14212</th>\n",
       "      <td>Galantamine is a reversible, competitive acetylcholinesterase (AChE) inhibitor and allosteric potentiating ligand of nicotinic acetylcholine receptors (nAChR-APL) that shares many common structural elements with morphinan-based opioids.</td>\n",
       "      <td>6</td>\n",
       "      <td>nAChR</td>\n",
       "      <td>Galantamine</td>\n",
       "      <td>[152, 157]</td>\n",
       "      <td>[0, 11]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>16.0</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8653</th>\n",
       "      <td>Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas PRA was down-regulated in the uterus and oviduct after ethanol consumption.</td>\n",
       "      <td>6</td>\n",
       "      <td>PRB</td>\n",
       "      <td>ethanol</td>\n",
       "      <td>[28, 31]</td>\n",
       "      <td>[73, 80]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1]</td>\n",
       "      <td>4.0</td>\n",
       "      <td>11.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3384</th>\n",
       "      <td>BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (L-VGCCs), which could contribute to reduced neuronal excitability.</td>\n",
       "      <td>6</td>\n",
       "      <td>GABA(A)R</td>\n",
       "      <td>barbiturates</td>\n",
       "      <td>[24, 32]</td>\n",
       "      <td>[55, 67]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>4.0</td>\n",
       "      <td>7.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12443</th>\n",
       "      <td>An HTS campaign identified several weak M5 PAMs (M5 EC50 &gt;10μM) with a structurally related isatin core that possessed a southern phenethyl ether linkage.</td>\n",
       "      <td>6</td>\n",
       "      <td>M5</td>\n",
       "      <td>phenethyl ether</td>\n",
       "      <td>[49, 51]</td>\n",
       "      <td>[130, 145]</td>\n",
       "      <td>[-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]</td>\n",
       "      <td>8.0</td>\n",
       "      <td>21.5</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                             text  \\\n",
       "12446  While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s >30μM) and a robust 20-fold leftward shift of the ACh CRC.   \n",
       "3477                                                                                                                                                                                                                                      Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor.   \n",
       "8655                                                                                                                                                                                  Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas PRA was down-regulated in the uterus and oviduct after ethanol consumption.   \n",
       "3387                                                                                                                                                  BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (L-VGCCs), which could contribute to reduced neuronal excitability.   \n",
       "8654                                                                                                                                                                                  Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas PRA was down-regulated in the uterus and oviduct after ethanol consumption.   \n",
       "13836                                                                                                                                                                                                          The recently discovered hyperinsulinism/hyperammonemia disorder showed that the loss of allosteric inhibition of GDH by GTP causes excessive secretion of insulin.   \n",
       "5378                                                                                                                                                                                                               The implications of our finding for mechanism of in vivo actions of rapamycin and for design of novel allosteric drugs targeting the proteasome are discussed.   \n",
       "3606                                                                                                                                                                                                                                                                                        Ifenprodil is an allosteric inhibitor of GluN1/GluN2B N-methyl-D-aspartate receptors.   \n",
       "15281                                                                                                                                                                                                                                       Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists.   \n",
       "3381                                                                                                                                                                                                                                          Benzodiazepines (BDZs) depress neuronal excitability via positive allosteric modulation of inhibitory GABA(A) receptors (GABA(A)R).   \n",
       "14216                                                                                                                                                     The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.   \n",
       "8650                                                                                                                                                                                  Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas PRA was down-regulated in the uterus and oviduct after ethanol consumption.   \n",
       "12445  While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s >30μM) and a robust 20-fold leftward shift of the ACh CRC.   \n",
       "9857                                                                                                                                                                                                                                                                           Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism.   \n",
       "13869                                                                                                               Because these speeds are significantly faster than the responses to antagonists, these data indicate that gallamine and dimethyl-W84 are allosteric ligands and actively induce a conformation of the M(2) receptor with a reduced affinity for its agonists.   \n",
       "8651                                                                                                                                                                                  Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas PRA was down-regulated in the uterus and oviduct after ethanol consumption.   \n",
       "5381                                                                                                                                                                                                                                                        Rapamycin is a canonical allosteric inhibitor of the mTOR kinase with immunosuppressive and pro-apoptotic activities.   \n",
       "12448  While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s >30μM) and a robust 20-fold leftward shift of the ACh CRC.   \n",
       "12447  While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s >30μM) and a robust 20-fold leftward shift of the ACh CRC.   \n",
       "12978                                                                                                                                                                                                                                   Diacylglycerol (DAG) acts as an allosteric activator of protein kinase C (PKC) and is converted to phosphatidic acid by DAG kinase (DGK).   \n",
       "12444  While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s >30μM) and a robust 20-fold leftward shift of the ACh CRC.   \n",
       "3608                                                                                                                                                                                                                                                                                        Ifenprodil is an allosteric inhibitor of GluN1/GluN2B N-methyl-D-aspartate receptors.   \n",
       "13508                                                                                                                                                                                                                                             Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors.   \n",
       "13506                                                                                                                                                               These data indicate that vecuronium, gallamine and pancuronium interact with an allosteric site on the muscarinic M2 receptor (located on the heart) and this may explain some of their cardiac side effects.   \n",
       "11212                                                                                                                                                                                        In addition to studies focused on the mechanisms of nuclear receptor function, additional work has illuminated the mechanism by which androgens are metabolized in selected tissues.   \n",
       "5377                                                                                                                                                                                                                                                We hypothesize that the rapamycin and related compounds bind to the α face and allosterically impact the proteasome function.   \n",
       "11238                                                                                                                                                                 A number of agents are being developed that target molecular abnormalities in IEN, have fewer or different side effects than tamoxifen, and may be effective in ER-negative or tamoxifen-resistant disease.   \n",
       "5379                                                                                                                                                                                                                                                                                                                            Rapamycin allosterically inhibits the proteasome.   \n",
       "12440                                                                                                                                                                                                                                                                         This Letter describes the further chemical optimization of the M5 PAM MLPCN probes ML129 and ML172.   \n",
       "3478                                                                                                            Herein, we report the pharmacological actions of Lu AF21934, a novel, selective, and brain-penetrant positive allosteric modulator (PAM) of the mGlu(4) receptor in the stress-induced hyperthermia (SIH), four-plate, marble-burying and Vogel's conflict tests.   \n",
       "9859                                                                                                                                                                                                                                                                                                 It is concluded that salicylates are allosteric inhibitors of ETA receptors.   \n",
       "4409                                                                                                                                                                                                However, one mGlu5 PAM, CPPHA (N-(4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl)-2-hydroxybenzamide), interacts with a separate allosteric site on mGlu5.   \n",
       "12441                                                                                                                                                                                                                                                                                                             Discovery of ML326: The first sub-micromolar, selective M5 PAM.   \n",
       "3386                                                                                                                                                  BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (L-VGCCs), which could contribute to reduced neuronal excitability.   \n",
       "12437  While SAR within the HTS series was very shallow and unable to be optimized, grafting the phenethyl ether linkage onto the ML129/ML172 cores led to the first sub-micromolar M5 PAM, ML326 (VU0467903), (human and rat M5 EC50s of 409nM and 500nM, respectively) with excellent mAChR selectivity (M1-M4 EC50s >30μM) and a robust 20-fold leftward shift of the ACh CRC.   \n",
       "4410                                                                                                                                                                                                However, one mGlu5 PAM, CPPHA (N-(4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl)-2-hydroxybenzamide), interacts with a separate allosteric site on mGlu5.   \n",
       "3383                                                                                                                                                                                                                                          Benzodiazepines (BDZs) depress neuronal excitability via positive allosteric modulation of inhibitory GABA(A) receptors (GABA(A)R).   \n",
       "14215                                                                                                                                                     The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.   \n",
       "1136                                                                                                                                                                                           A great deal of information has now accumulated pertaining to the mechanisms by which nuclear receptors, such as the androgen receptor, modulate the activity of responsive genes.   \n",
       "4413                                                                                                                               Using cell-based assays and brain slice preparations, we characterized the interaction of a potent and efficacious mGlu5 PAM from the CPPHA series termed NCFP (N-(4-chloro-2-((4-fluoro-1,3-dioxoisoindolin-2-yl)methyl)phenyl)picolinamide).   \n",
       "3385                                                                                                                                                  BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (L-VGCCs), which could contribute to reduced neuronal excitability.   \n",
       "3382                                                                                                                                                                                                                                          Benzodiazepines (BDZs) depress neuronal excitability via positive allosteric modulation of inhibitory GABA(A) receptors (GABA(A)R).   \n",
       "4411                                                                                                                               Using cell-based assays and brain slice preparations, we characterized the interaction of a potent and efficacious mGlu5 PAM from the CPPHA series termed NCFP (N-(4-chloro-2-((4-fluoro-1,3-dioxoisoindolin-2-yl)methyl)phenyl)picolinamide).   \n",
       "12977                                                                                                                                                                                                                                   Diacylglycerol (DAG) acts as an allosteric activator of protein kinase C (PKC) and is converted to phosphatidic acid by DAG kinase (DGK).   \n",
       "14214                                                                                                                                                     The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.   \n",
       "12976                                                                                                                                                                                                                                   Diacylglycerol (DAG) acts as an allosteric activator of protein kinase C (PKC) and is converted to phosphatidic acid by DAG kinase (DGK).   \n",
       "8652                                                                                                                                                                                  Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas PRA was down-regulated in the uterus and oviduct after ethanol consumption.   \n",
       "4425                                                                                                                                                                                                                                                                            Evidence for a new binding mode to GSK-3: allosteric regulation by the marine compound palinurin.   \n",
       "14213                                                                                                                                                     The structurally diverse opioids codeine and eseroline, like galantamine, are also nAChR-APL that have greatly diminished affinity for AChE, representing potential lead compounds for selective nAChR-APL development.   \n",
       "3763                                                                                                                                                                                                                                                                     Hydrogen sulfide as an allosteric modulator of ATP-sensitive potassium channels in colonic inflammation.   \n",
       "3607                                                                                                                                                                                                                                                                                        Ifenprodil is an allosteric inhibitor of GluN1/GluN2B N-methyl-D-aspartate receptors.   \n",
       "14212                                                                                                                                Galantamine is a reversible, competitive acetylcholinesterase (AChE) inhibitor and allosteric potentiating ligand of nicotinic acetylcholine receptors (nAChR-APL) that shares many common structural elements with morphinan-based opioids.   \n",
       "8653                                                                                                                                                                                  Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas PRA was down-regulated in the uterus and oviduct after ethanol consumption.   \n",
       "3384                                                                                                                                                  BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (L-VGCCs), which could contribute to reduced neuronal excitability.   \n",
       "12443                                                                                                                                                                                                                  An HTS campaign identified several weak M5 PAMs (M5 EC50 >10μM) with a structurally related isatin core that possessed a southern phenethyl ether linkage.   \n",
       "\n",
       "       labels                           entity1  \\\n",
       "12446       6                                M5   \n",
       "3477        6                             mGlu₄   \n",
       "8655        6                               PRB   \n",
       "3387        6                          GABA(A)R   \n",
       "8654        6                               PRA   \n",
       "13836       6                               GDH   \n",
       "5378        6                        proteasome   \n",
       "3606        6                             GluN1   \n",
       "15281       6           CC-chemokine receptor 4   \n",
       "3381        6                          GABA(A)R   \n",
       "14216       6                             nAChR   \n",
       "8650        6                               PRA   \n",
       "12445       6                                M5   \n",
       "9857        6                     ETA receptors   \n",
       "13869       6                     M(2) receptor   \n",
       "8651        6                               PRB   \n",
       "5381        6                            kinase   \n",
       "12448       6                                M5   \n",
       "12447       6                                M5   \n",
       "12978       6                               PKC   \n",
       "12444       6                                M5   \n",
       "3608        6    N-methyl-D-aspartate receptors   \n",
       "13508       6     human muscarinic M2 receptors   \n",
       "13506       6            muscarinic M2 receptor   \n",
       "11212       6                  nuclear receptor   \n",
       "5377        6                        proteasome   \n",
       "11238       6                                ER   \n",
       "5379        6                        proteasome   \n",
       "12440       6                                M5   \n",
       "3478        6                           mGlu(4)   \n",
       "9859        6                     ETA receptors   \n",
       "4409        6                             mGlu5   \n",
       "12441       6                                M5   \n",
       "3386        6                          GABA(A)R   \n",
       "12437       6                                M5   \n",
       "4410        6                             mGlu5   \n",
       "3383        6                          GABA(A)R   \n",
       "14215       6                             nAChR   \n",
       "1136        6                 nuclear receptors   \n",
       "4413        6                             mGlu5   \n",
       "3385        6                          GABA(A)R   \n",
       "3382        6                 GABA(A) receptors   \n",
       "4411        6                             mGlu5   \n",
       "12977       6                  protein kinase C   \n",
       "14214       6                             nAChR   \n",
       "12976       6                               PKC   \n",
       "8652        6                               PRA   \n",
       "4425        6                             GSK-3   \n",
       "14213       6                             nAChR   \n",
       "3763        6  ATP-sensitive potassium channels   \n",
       "3607        6                            GluN2B   \n",
       "14212       6                             nAChR   \n",
       "8653        6                               PRB   \n",
       "3384        6                          GABA(A)R   \n",
       "12443       6                                M5   \n",
       "\n",
       "                                                                                        entity2  \\\n",
       "12446                                                                                     ML172   \n",
       "3477                                                                                 Lu AF21934   \n",
       "8655                                                                                  melatonin   \n",
       "3387                                                                                       BDZs   \n",
       "8654                                                                                  melatonin   \n",
       "13836                                                                                       GTP   \n",
       "5378                                                                                  rapamycin   \n",
       "3606                                                                                 Ifenprodil   \n",
       "15281                                                                 indazole arylsulfonamides   \n",
       "3381                                                                                       BDZs   \n",
       "14216                                                                                 eseroline   \n",
       "8650                                                                                    ethanol   \n",
       "12445                                                                                     ML129   \n",
       "9857                                                                                    Aspirin   \n",
       "13869                                                                                 gallamine   \n",
       "8651                                                                                    ethanol   \n",
       "5381                                                                                  Rapamycin   \n",
       "12448                                                                                     ML326   \n",
       "12447                                                                                     ML326   \n",
       "12978                                                                                       DAG   \n",
       "12444                                                                           phenethyl ether   \n",
       "3608                                                                                 Ifenprodil   \n",
       "13508                                                                                vecuronium   \n",
       "13506                                                                                 gallamine   \n",
       "11212                                                                                 androgens   \n",
       "5377                                                                                  rapamycin   \n",
       "11238                                                                                 tamoxifen   \n",
       "5379                                                                                  Rapamycin   \n",
       "12440                                                                                     ML172   \n",
       "3478                                                                                 Lu AF21934   \n",
       "9859                                                                                salicylates   \n",
       "4409                                                                                      CPPHA   \n",
       "12441                                                                                     ML326   \n",
       "3386                                                                              neurosteroids   \n",
       "12437                                                                                 VU0467903   \n",
       "4410   N-(4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl)-2-hydroxybenzamide   \n",
       "3383                                                                            Benzodiazepines   \n",
       "14215                                                                                 eseroline   \n",
       "1136                                                                                   androgen   \n",
       "4413               N-(4-chloro-2-((4-fluoro-1,3-dioxoisoindolin-2-yl)methyl)phenyl)picolinamide   \n",
       "3385                                                                                    ethanol   \n",
       "3382                                                                            Benzodiazepines   \n",
       "4411                                                                                      CPPHA   \n",
       "12977                                                                                       DAG   \n",
       "14214                                                                                   codeine   \n",
       "12976                                                                            Diacylglycerol   \n",
       "8652                                                                                    ethanol   \n",
       "4425                                                                                  palinurin   \n",
       "14213                                                                                   codeine   \n",
       "3763                                                                           Hydrogen sulfide   \n",
       "3607                                                                                 Ifenprodil   \n",
       "14212                                                                               Galantamine   \n",
       "8653                                                                                    ethanol   \n",
       "3384                                                                               barbiturates   \n",
       "12443                                                                           phenethyl ether   \n",
       "\n",
       "            span1       span2  \\\n",
       "12446  [173, 175]  [129, 134]   \n",
       "3477   [120, 125]    [52, 62]   \n",
       "8655     [28, 31]    [81, 90]   \n",
       "3387     [24, 32]      [0, 4]   \n",
       "8654     [20, 23]    [81, 90]   \n",
       "13836  [113, 116]  [120, 123]   \n",
       "5378   [133, 143]    [68, 77]   \n",
       "3606     [41, 46]     [0, 10]   \n",
       "15281   [90, 113]    [50, 75]   \n",
       "3381   [121, 129]    [17, 21]   \n",
       "14216  [193, 198]    [45, 54]   \n",
       "8650     [20, 23]    [61, 68]   \n",
       "12445  [173, 175]  [123, 128]   \n",
       "9857     [49, 62]      [0, 7]   \n",
       "13869  [198, 211]  [106, 115]   \n",
       "8651     [28, 31]    [61, 68]   \n",
       "5381     [58, 64]      [0, 9]   \n",
       "12448  [215, 217]  [181, 186]   \n",
       "12447  [173, 175]  [181, 186]   \n",
       "12978    [74, 77]    [16, 19]   \n",
       "12444  [173, 175]   [90, 105]   \n",
       "3608     [54, 84]     [0, 10]   \n",
       "13508   [97, 126]    [53, 63]   \n",
       "13506  [103, 125]    [37, 46]   \n",
       "11212    [52, 68]  [134, 143]   \n",
       "5377   [105, 115]    [24, 33]   \n",
       "11238  [160, 162]  [125, 134]   \n",
       "5379     [38, 48]      [0, 9]   \n",
       "12440    [63, 65]    [93, 98]   \n",
       "3478   [144, 151]    [49, 59]   \n",
       "9859     [62, 75]    [21, 32]   \n",
       "4409     [13, 18]    [24, 29]   \n",
       "12441    [56, 58]    [13, 18]   \n",
       "3386     [24, 32]    [82, 95]   \n",
       "12437  [173, 175]  [188, 197]   \n",
       "4410     [13, 18]   [31, 119]   \n",
       "3383   [121, 129]     [0, 15]   \n",
       "14215    [83, 88]    [45, 54]   \n",
       "1136    [86, 103]  [117, 125]   \n",
       "4413   [115, 120]  [160, 236]   \n",
       "3385     [24, 32]    [69, 76]   \n",
       "3382   [102, 119]     [0, 15]   \n",
       "4411   [115, 120]  [134, 139]   \n",
       "12977    [56, 72]    [16, 19]   \n",
       "14214  [193, 198]    [33, 40]   \n",
       "12976    [74, 77]     [0, 14]   \n",
       "8652     [20, 23]    [73, 80]   \n",
       "4425     [35, 40]    [87, 96]   \n",
       "14213    [83, 88]    [33, 40]   \n",
       "3763     [47, 79]     [0, 16]   \n",
       "3607     [47, 53]     [0, 10]   \n",
       "14212  [152, 157]     [0, 11]   \n",
       "8653     [28, 31]    [73, 80]   \n",
       "3384     [24, 32]    [55, 67]   \n",
       "12443    [49, 51]  [130, 145]   \n",
       "\n",
       "                                                                                                    weak_labels  \\\n",
       "12446  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "3477      [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, 6, -1, -1, -1, -1, -1, -1, 9]   \n",
       "8655     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1]   \n",
       "3387      [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "8654     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1]   \n",
       "13836    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "5378    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "3606     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "15281    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 5, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "3381      [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, 6, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "14216   [-1, -1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "8650     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1]   \n",
       "12445  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "9857     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "13869        [-1, -1, -1, -1, -1, 1, -1, -1, 2, -1, -1, -1, 3, -1, -1, 4, 5, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "8651     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1]   \n",
       "5381     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "12448  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "12447  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "12978     [-1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, 8, -1]   \n",
       "12444  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "3608     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "13508    [-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "13506    [-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "11212  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "5377     [-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "11238  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "5379     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "12440  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "3478      [-1, -1, -1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, -1, -1, -1, -1, 6, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "9859     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "4409     [-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "12441  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "3386      [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "12437  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "4410     [-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "3383      [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, 6, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "14215   [-1, -1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "1136    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "4413    [-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "3385      [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "3382      [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, 6, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "4411    [-1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "12977     [-1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, 8, -1]   \n",
       "14214   [-1, -1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "12976     [-1, -1, -1, -1, -1, -1, 2, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, 8, -1]   \n",
       "8652     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1]   \n",
       "4425     [-1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "14213   [-1, -1, -1, -1, -1, 1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "3763     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 6, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "3607     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "14212    [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1]   \n",
       "8653     [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 8, -1]   \n",
       "3384      [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, 3, 3, -1, -1, -1, 6, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "12443  [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1]   \n",
       "\n",
       "       entity1_index  entity2_index  \n",
       "12446           28.0           21.0  \n",
       "3477            16.0            6.5  \n",
       "8655             4.0           11.0  \n",
       "3387             4.0            0.0  \n",
       "8654             2.0           11.0  \n",
       "13836           13.0           15.0  \n",
       "5378            22.0           12.0  \n",
       "3606             6.0            0.0  \n",
       "15281           10.0            5.5  \n",
       "3381            13.0            1.0  \n",
       "14216           25.0            6.0  \n",
       "8650             2.0            9.0  \n",
       "12445           28.0           21.0  \n",
       "9857             6.5            0.0  \n",
       "13869           28.5           15.0  \n",
       "8651             4.0            9.0  \n",
       "5381             9.0            0.0  \n",
       "12448           35.0           30.0  \n",
       "12447           28.0           30.0  \n",
       "12978           11.0            1.0  \n",
       "12444           28.0           16.5  \n",
       "3608             7.5            0.0  \n",
       "13508           12.5            6.0  \n",
       "13506           16.0            5.0  \n",
       "11212            9.5           20.0  \n",
       "5377            17.0            4.0  \n",
       "11238           26.0           20.0  \n",
       "5379             4.0            0.0  \n",
       "12440            9.0           15.0  \n",
       "3478            20.0            7.5  \n",
       "9859             9.5            4.0  \n",
       "4409             2.0            4.0  \n",
       "12441            7.0            2.0  \n",
       "3386             4.0           10.0  \n",
       "12437           28.0           31.0  \n",
       "4410             2.0            5.0  \n",
       "3383            13.0            0.0  \n",
       "14215           11.0            6.0  \n",
       "1136            14.5           19.0  \n",
       "4413            16.0           24.0  \n",
       "3385             4.0            8.0  \n",
       "3382            11.5            0.0  \n",
       "4411            16.0           20.0  \n",
       "12977            9.0            1.0  \n",
       "14214           25.0            4.0  \n",
       "12976           11.0            0.0  \n",
       "8652             2.0           11.0  \n",
       "4425             7.0           14.0  \n",
       "14213           11.0            4.0  \n",
       "3763             8.0            0.5  \n",
       "3607             6.0            0.0  \n",
       "14212           16.0            0.0  \n",
       "8653             4.0           11.0  \n",
       "3384             4.0            7.0  \n",
       "12443            8.0           21.5  "
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Cell to inspect the dev set for a given label \n",
    "label = 'Modulator' # Change this variable\n",
    "pd.set_option('display.max_colwidth', 1000)\n",
    "label6 = train_df[train_df['labels'] == int(label_to_idx[label])]\n",
    "# save the dev set to a file\n",
    "df2 = li.chemprot_enhanced(label6)\n",
    "df2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1\n",
      "3\n",
      "9\n",
      "29\n",
      "33\n",
      "36\n",
      "38\n",
      "40\n",
      "41\n",
      "49\n",
      "53\n",
      "count 11\n"
     ]
    }
   ],
   "source": [
    "count = 0\n",
    "for i in range(len(df2)):\n",
    "    weak_label = df2.iloc[i]['weak_labels'][17]\n",
    "    if weak_label != -1:\n",
    "        print(i)\n",
    "        count+=1\n",
    "print('count', count)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 55/55 [00:00<00:00, 26154.96it/s]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "array([[-1],\n",
       "       [ 6],\n",
       "       [-1],\n",
       "       [ 6],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [ 6],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [ 6],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [ 6],\n",
       "       [ 6],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [ 6],\n",
       "       [-1],\n",
       "       [ 6],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [ 6],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [ 6],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [ 6],\n",
       "       [ 6],\n",
       "       [-1],\n",
       "       [-1],\n",
       "       [ 6],\n",
       "       [-1]])"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "L_train = applier.apply(df=df2)\n",
    "L_train"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>labels</th>\n",
       "      <th>entity1</th>\n",
       "      <th>entity2</th>\n",
       "      <th>span1</th>\n",
       "      <th>span2</th>\n",
       "      <th>weak_labels</th>\n",
       "      <th>18th_weak_label</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [text, labels, entity1, entity2, span1, span2, weak_labels, 18th_weak_label]\n",
       "Index: []"
      ]
     },
     "execution_count": 57,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "\n",
    "# Cell to inspect the dev set for a given label \n",
    "label = 'Modulator' # Change this variable\n",
    "pd.set_option('display.max_colwidth', 1000)\n",
    "\n",
    "\n",
    "def get_18th_element(lst):\n",
    "    return lst[16] if len(lst) >16  else None\n",
    "\n",
    "# Create a copy of the DataFrame\n",
    "train_df_copy = train_df.copy()\n",
    "\n",
    "# Apply the function to the copy\n",
    "train_df_copy['18th_weak_label'] = train_df_copy['weak_labels'].apply(get_18th_element)\n",
    "\n",
    "# Filter the copy\n",
    "label6_all = train_df[train_df_copy['18th_weak_label'] == 6]\n",
    "\n",
    "# Continue with your code\n",
    "df3 = li.chemprot_enhanced(label6_all)\n",
    "df3"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Main Work"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "df2.to_csv(f\"./dev_{label}.csv\")\n",
    "chemprot6 = li.df_to_chemprot(li.chemprot_enhanced(label6))\n",
    "li.save_dataset(chemprot6, f\"./dev_{label}.json\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>labels</th>\n",
       "      <th>entity1</th>\n",
       "      <th>entity2</th>\n",
       "      <th>span1</th>\n",
       "      <th>span2</th>\n",
       "      <th>weak_labels</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [text, labels, entity1, entity2, span1, span2, weak_labels]\n",
       "Index: []"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Cell to inspect dev set for a given keyword (to inspect conflicts). Note: this doesn't work with \"+\" \n",
    "keyword = 'iPad' # Change this word\n",
    "pd.set_option('display.max_colwidth', 1000)\n",
    "dev_df[dev_df['text'].str.contains(keyword)]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Evaluation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 235,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 131781/131781 [02:54<00:00, 755.05it/s]\n",
      "100%|██████████| 5805/5805 [00:07<00:00, 754.68it/s]\n",
      "100%|██████████| 17402/17402 [00:22<00:00, 756.63it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Train Coverage: 0.6395003832115403\n",
      "Valid Coverage: 0.6396210163652024\n",
      "Test Coverage: 0.6375703942075623\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>j</th>\n",
       "      <th>Polarity</th>\n",
       "      <th>Coverage</th>\n",
       "      <th>Overlaps</th>\n",
       "      <th>Conflicts</th>\n",
       "      <th>Conflict Ratio</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>lf_blouse</th>\n",
       "      <td>0</td>\n",
       "      <td>[0]</td>\n",
       "      <td>0.001206</td>\n",
       "      <td>0.000861</td>\n",
       "      <td>0.000517</td>\n",
       "      <td>0.428571</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>lf_shirt</th>\n",
       "      <td>1</td>\n",
       "      <td>[0]</td>\n",
       "      <td>0.009991</td>\n",
       "      <td>0.006202</td>\n",
       "      <td>0.005857</td>\n",
       "      <td>0.586207</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>lf_scarf</th>\n",
       "      <td>2</td>\n",
       "      <td>[0]</td>\n",
       "      <td>0.001378</td>\n",
       "      <td>0.000689</td>\n",
       "      <td>0.000689</td>\n",
       "      <td>0.500000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>lf_jacket</th>\n",
       "      <td>3</td>\n",
       "      <td>[0]</td>\n",
       "      <td>0.004479</td>\n",
       "      <td>0.002239</td>\n",
       "      <td>0.002239</td>\n",
       "      <td>0.500000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>lf_underwear</th>\n",
       "      <td>4</td>\n",
       "      <td>[0]</td>\n",
       "      <td>0.001206</td>\n",
       "      <td>0.000517</td>\n",
       "      <td>0.000345</td>\n",
       "      <td>0.285714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>lf_bracelet+watch</th>\n",
       "      <td>225</td>\n",
       "      <td>[29]</td>\n",
       "      <td>0.003101</td>\n",
       "      <td>0.003101</td>\n",
       "      <td>0.003101</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>lf_electronic+case</th>\n",
       "      <td>226</td>\n",
       "      <td>[30]</td>\n",
       "      <td>0.001206</td>\n",
       "      <td>0.001034</td>\n",
       "      <td>0.001034</td>\n",
       "      <td>0.857143</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>lf_ipod</th>\n",
       "      <td>227</td>\n",
       "      <td>[30]</td>\n",
       "      <td>0.012231</td>\n",
       "      <td>0.008786</td>\n",
       "      <td>0.007407</td>\n",
       "      <td>0.605634</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>lf_ipad</th>\n",
       "      <td>228</td>\n",
       "      <td>[30]</td>\n",
       "      <td>0.008613</td>\n",
       "      <td>0.006546</td>\n",
       "      <td>0.005168</td>\n",
       "      <td>0.600000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>lf_iphone</th>\n",
       "      <td>229</td>\n",
       "      <td>[30]</td>\n",
       "      <td>0.009991</td>\n",
       "      <td>0.007063</td>\n",
       "      <td>0.005340</td>\n",
       "      <td>0.534483</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>230 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                      j Polarity  Coverage  Overlaps  Conflicts  \\\n",
       "lf_blouse             0      [0]  0.001206  0.000861   0.000517   \n",
       "lf_shirt              1      [0]  0.009991  0.006202   0.005857   \n",
       "lf_scarf              2      [0]  0.001378  0.000689   0.000689   \n",
       "lf_jacket             3      [0]  0.004479  0.002239   0.002239   \n",
       "lf_underwear          4      [0]  0.001206  0.000517   0.000345   \n",
       "...                 ...      ...       ...       ...        ...   \n",
       "lf_bracelet+watch   225     [29]  0.003101  0.003101   0.003101   \n",
       "lf_electronic+case  226     [30]  0.001206  0.001034   0.001034   \n",
       "lf_ipod             227     [30]  0.012231  0.008786   0.007407   \n",
       "lf_ipad             228     [30]  0.008613  0.006546   0.005168   \n",
       "lf_iphone           229     [30]  0.009991  0.007063   0.005340   \n",
       "\n",
       "                    Conflict Ratio  \n",
       "lf_blouse                 0.428571  \n",
       "lf_shirt                  0.586207  \n",
       "lf_scarf                  0.500000  \n",
       "lf_jacket                 0.500000  \n",
       "lf_underwear              0.285714  \n",
       "...                            ...  \n",
       "lf_bracelet+watch         1.000000  \n",
       "lf_electronic+case        0.857143  \n",
       "lf_ipod                   0.605634  \n",
       "lf_ipad                   0.600000  \n",
       "lf_iphone                 0.534483  \n",
       "\n",
       "[230 rows x 6 columns]"
      ]
     },
     "execution_count": 235,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "L_train = apply_LFs(lfs, train_df)\n",
    "L_valid = apply_LFs(lfs, valid_df)\n",
    "L_test = apply_LFs(lfs, test_df)\n",
    "\n",
    "print(\"Train Coverage:\", calc_coverage(L_train))\n",
    "print(\"Valid Coverage:\", calc_coverage(L_valid))\n",
    "print(\"Test Coverage:\", calc_coverage(L_test))\n",
    "\n",
    "lf_analysis = LFAnalysis(L=L_valid, lfs=lfs).lf_summary()\n",
    "\n",
    "# Calculates how many of an LFs votes result in conflicts (helpful signal for debugging LFs)\n",
    "lf_analysis['Conflict Ratio'] = lf_analysis['Conflicts'] / lf_analysis['Coverage']\n",
    "lf_analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 236,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "lf_poncho              1.000000\n",
       "lf_portable battery    1.000000\n",
       "lf_bracelet+watch      1.000000\n",
       "lf_card game           1.000000\n",
       "lf_tent+daughter       1.000000\n",
       "lf_car+1:              1.000000\n",
       "lf_athletic            1.000000\n",
       "lf_t-shirt             1.000000\n",
       "lf_video+conversion    1.000000\n",
       "lf_basketball+shoe     1.000000\n",
       "lf_cage                1.000000\n",
       "lf_laptop stand        1.000000\n",
       "lf_folders             1.000000\n",
       "lf_headphone+studio    1.000000\n",
       "lf_pop+classic         1.000000\n",
       "lf_toners              1.000000\n",
       "lf_acne treatment      1.000000\n",
       "lf_skin care           1.000000\n",
       "lf_waist trimmer       1.000000\n",
       "lf_nail+paint          1.000000\n",
       "lf_gummi               1.000000\n",
       "lf_laptop+battery      0.909091\n",
       "lf_punch               0.875000\n",
       "lf_air+drain           0.875000\n",
       "lf_electronic+case     0.857143\n",
       "lf_tent+son            0.842105\n",
       "lf_laptop+case         0.833333\n",
       "Name: Conflict Ratio, dtype: float64"
      ]
     },
     "execution_count": 236,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# List LFs for which 'Conflict Ratio' is above some threshold (helpful for debugging)\n",
    "lf_analysis[lf_analysis['Conflict Ratio'] > 0.8]['Conflict Ratio'].sort_values(ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 237,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.6649519890260631"
      ]
     },
     "execution_count": 237,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Calculate accuracy on the validation set (Ideally do this only at the end)\n",
    "majority_model = MajorityLabelVoter(31)\n",
    "preds_valid = majority_model.predict(L=L_valid)\n",
    "(preds_valid[preds_valid != -1] == valid_df[preds_valid != -1].labels.values).mean()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 238,
   "metadata": {},
   "outputs": [],
   "source": [
    "json.dump(keywords, open(\"amazon_LFs_v1.json\", \"w\"), indent=8)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Replace the LFs for a given dataset (in wrench format)\n",
    "# dataset_name = \"dbpedia\"\n",
    "\n",
    "# train_json = json.load(open(f\"../weak_datasets/{dataset_name}/train.json\", \"r\"))\n",
    "# for idx in train_json:\n",
    "#     train_json[idx]['weak_labels'] = [int(i) for i in list(L_train[int(idx)])]\n",
    "    \n",
    "# valid_json = json.load(open(f\"../weak_datasets/{dataset_name}/valid.json\", \"r\"))\n",
    "# for idx in valid_json:\n",
    "#     valid_json[idx]['weak_labels'] = [int(i) for i in list(L_valid[int(idx)])]\n",
    "    \n",
    "# test_json = json.load(open(f\"../weak_datasets/{dataset_name}/test.json\", \"r\"))\n",
    "# for idx in test_json:\n",
    "#     test_json[idx]['weak_labels'] = [int(i) for i in list(L_test[int(idx)])]\n",
    "\n",
    "# json.dump(train_json, open(f\"../weak_datasets/{dataset_name}/train.json\", 'w'), indent=4)\n",
    "# json.dump(valid_json, open(f\"../weak_datasets/{dataset_name}/valid.json\", 'w'), indent=4)\n",
    "# json.dump(test_json, open(f\"../weak_datasets/{dataset_name}/test.json\", 'w'), indent=4)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.11"
  },
  "vscode": {
   "interpreter": {
    "hash": "3e41b164576941b46182852b40d7161f07e36b5af4c9af87265f406ae525ca4b"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
